Taigo Horiguchi, Keiko Miyoshi and Takafumi Noma : 生化学実習書 (第14版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2020.
2.
Taigo Horiguchi, Keiko Miyoshi and Takafumi Noma : 生化学実習書 (第13版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2019.
3.
Taigo Horiguchi, Keiko Miyoshi and Takafumi Noma : 生化学実習書 (第12版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2018.
4.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第11版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2017.
5.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第10版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2016.
6.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第9版1刷), 徳島大学大学院医歯薬学研究部分子医化学分野, Tokushima, May 2015.
7.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第8版1刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2014.
8.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第7版1刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2013.
9.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第6版1刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2012.
10.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura and Takafumi Noma : 生化学実習書 (第5版2刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2011.
11.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第5版1刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2010.
12.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第4版10刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2009.
13.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第3版10刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2008.
14.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第3版9刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2007.
15.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第3版8刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2006.
16.
Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : 生化学実習書 (第3版7刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2005.
17.
Taigo Horiguchi, Akemichi Ueno, Keiko Miyoshi and Takafumi Noma : 生化学実習書 (第3版6刷), 徳島大学大学院ヘルスバイオサイエンス研究部分子医化学分野, Tokushima, May 2004.
18.
Taigo Horiguchi, Akemichi Ueno, Keiko Miyoshi and Takafumi Noma : 生化学実習書 (第3版5刷), 徳島大学歯学部口腔生化学講座, Tokushima, May 2003.
19.
Taigo Horiguchi, Akemichi Ueno and Keiko Miyoshi : 生化学実習書 (第3版4刷), 徳島大学歯学部口腔生化学講座, Tokushima, May 2002.
Academic Paper (Judged Full Paper):
1.
Motoharu Sarubo, Yasuhiro Mouri, Akira Moromizato, Azusa Yamada, Shengjan Jin, Wenhua Shao, Hiroko Hagita, Keiko Miyoshi and Yasusei Kudo : Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma., Scientific Reports, Vol.14, No.1, 6767, 2024.
(Summary)
Head and neck squamous cell carcinoma (HNSCC) is a significant healthcare burden globally. Previous research using single-cell transcriptome analysis identified TGFBI as a crucial marker for the partial-epithelial-mesenchymal transition (partial-EMT) program. However, the precise role of TGFBI in HNSCC progression remains unclear. Therefore, our study aimed to clarify the impact of TGFBI on the malignant behavior of HNSCC cells. Through RNA-sequencing data from the TCGA database, we validated that increased TGFBI expression correlates with a higher occurrence of lymph node metastasis and unfavorable prognosis in HNSCC cases. Functional experiments demonstrated that TGFBI overexpression enhances the ability of sphere formation, indicating stem-cell-like properties. Conversely, TGFBI depletion reduces sphere formation and suppresses the expression of cancer stem cell (CSC) markers. RNA-sequencing analysis of TGFBI-overexpressing and control HNSCC cells revealed TAGLN as a downstream effector mediating TGFBI-induced sphere formation. Remarkably, TAGLN depletion abolished TGFBI-induced sphere formation, while its overexpression rescued the suppressed sphere formation caused by TGFBI depletion. Moreover, elevated TAGLN expression showed correlations with the expression of TGFBI and partial-EMT-related genes in HNSCC cases. In conclusion, our findings suggest that TGFBI may promote CSC properties through the upregulation of TAGLN. These novel insights shed light on the involvement of the TGFBI-TAGLN axis in HNSCC progression and hold implications for the development of targeted therapies.
(Keyword)
Humans / Squamous Cell Carcinoma of Head and Neck / Carcinoma, Squamous Cell / Head and Neck Neoplasms / Cell Line, Tumor / Neoplastic Stem Cells / Epithelial-Mesenchymal Transition / RNA / Gene Expression Regulation, Neoplastic
Shengjian Jin, Takaaki Tsunematsu, Taigo Horiguchi, Yasuhiro Mouri, Wenhua Shao, Keiko Miyoshi, Hiroko Hagita, Motoharu Sarubo, Natsumi Fujiwara, Qi Guangying, Naozumi Ishimaru and Yasusei Kudo : Involvement of the OTUB1-YAP1 axis in driving malignant behaviors of head and neck squamous cell carcinoma., Cancer Medicine, Vol.12, No.24, 22156-22169, 2023.
(Summary)
This study highlights the critical role of OTUB1 in HNSCC progression via modulating YAP1. Targeting the OTUB1-YAP1 axis holds promise as a potential therapeutic strategy for HNSCC treatment.
(Keyword)
deubiquitinating enzyme (DUB) / head and neck squamous cell carcinoma / invasion / OTUB1 / YAP
Intan Ruspita, Pragnya Das, Keiko Miyoshi, Takafumi Noma, L Malcolm Snead and Marianna Bei : Enam expression is regulated by Msx2., Developmental Dynamics, 2023.
(Summary)
Collectively, these results illustrate that Enam gene expression is controlled by Msx2 in a spatio-temporal manner. They also suggest that Msx2 may interact with other transcription factors to control spatial and temporal expression of Enam and hence amelogenesis and enamel biomineralization.
Taigo Horiguchi, Ayako Tanimura, Keiko Miyoshi, Hiroko Hagita, Hisanori Minami and Takafumi Noma : The Effect of Heterozygous Mutation of Adenylate Kinase 2 Gene on Neutrophil Differentiation., International Journal of Molecular Sciences, Vol.23, 16089, 2022.
(Summary)
Mitochondrial ATP production plays an important role in most cellular activities, including growth and differentiation. Previously we reported that Adenylate kinase 2 (AK2) is the main ADP supplier in the mitochondrial intermembrane space in hematopoietic cells, especially in the bone marrow. AK2 is crucial for the production of neutrophils and T cells, and its deficiency causes reticular dysgenesis. However, the relationship between ADP supply by AK2 and neutrophil differentiation remains unclear. In this study, we used CRISPR/Cas9 technology to establish two heterozygous AK2 knock-out HL-60 clones as models for reticular dysgenesis. Their AK2 activities were about half that in the wild-type (WT). Furthermore, neutrophil differentiation was impaired in one of the clones. In silico analysis predicted that the obtained mutations might cause a structural change in AK2. Time course microarray analysis of the WT and mutants revealed that similar gene clusters responded to all-trans retinoic acid treatment, but their expression was lower in the mutants than in WT. Application of fructose partially restored neutrophil differentiation in the heterozygous knock-out HL-60 clone after all-trans retinoic acid treatment. Collectively, our study suggests that the mutation of N-terminal region in AK2 might play a role in AK2-dependent neutrophil differentiation and fructose could be used to treat AK2 deficiency.
Yoshiko Yamamura, Keiko Miyoshi, Yasuhiro Mouri, Yasusei Kudo and Youji Miyamoto : miR 155 5p can be involved in acquisition of osseointegration on titanium surface, In Vitro Cellular & Developmental Biology. Animal, Vol.58, No.8, 693-701, 2022.
(Summary)
Dental implants made of titanium are commonly used. Although titanium implants succeed by osseointegration with bone, the detailed molecular mechanism of osseointegration is unclear. To clarify the involvement of microRNA (miRNA) in the acquisition of osseointegration on titanium, here we compared the miRNA expression profiles of mouse osteoblast-like cells (MC3T3-E1) cultured on titanium-, gold-, and stainless steel-coating glass dishes by microarray analysis. Three kinds of metals, namely titanium, gold, and stainless steel, were coated on the surface of the glass dishes by sputtering with similar roughness and shape of their surface. After MC3T3-E1 cells were cultured on the dishes without coating or coating with titanium, gold, or stainless steel for 6 h, total RNA was extracted, and miRNA expression was analyzed by microarray. To confirm the expression of the selected miRNA during osteogenic differentiation of MC3T3-E1 cells, real-time PCR analysis was performed. Furthermore, the effects of selected miRNA were examined by ectopic overexpression in MC3T3-E1 cells. The microarray analysis revealed that the expressions of miR-155-5p and miR-7023-3p were significantly increased in MC3T3-E1 cells cultured on titanium-coating glass dishes, compared to non-coating, gold-, and stainless steel-coating glass dishes. Interestingly, miR-155-5p was upregulated during osteogenic differentiation of MC3T3-E1 cells. Furthermore, overexpression of miR-155-5p enhanced the expression of Runx2 and Col1a1. In this study, miR-155-5p may be involved in the acquisition of osseointegration on titanium implant via upregulating osteogenic differentiation-related genes.
Satoru Kisoda, Yasuhiro Mouri, Naoya Kitamura, Tetsuya Yamamoto, Keiko Miyoshi and Yasusei Kudo : The role of partial-EMT in the progression of head and neck squamous cell carcinoma., Journal of Oral Biosciences, Vol.64, No.2, 176-182, 2022.
(Summary)
In this review, we highlight the features of partial-EMT in HNSCC by summarizing previous studies. Moreover, we discuss the therapeutic potential for targeting partial-EMT.
(Keyword)
Carcinoma, Squamous Cell / Epithelial-Mesenchymal Transition / Head and Neck Neoplasms / Humans / Lymphatic Metastasis / Squamous Cell Carcinoma of Head and Neck
Susumu Tadokoro, Reiko Tokuyama-Toda, Seiko Tatehara, Shinji Ide, Hirochika Umeki, Keiko Miyoshi, Takafumi Noma and Kazuhito Satomura : A New Induction Method for the Controlled Differentiation of Human-Induced Pluripotent Stem Cells Using Frozen Sections, Cells, Vol.10(11), No.11, 2827, 2021.
(Summary)
Considering that every tissue/organ has the most suitable microenvironment for its functional cells, controlling induced pluripotent stem cell (iPSC) differentiation by culture on frozen sections having a suitable microenvironment is possible. Induced PSCs were cultured on frozen sections of the liver, the brain, the spinal cord, and cover glasses (control) for 9 days. The iPSCs cultured on the sections of the liver resembled hepatocytes, whereas those on sections of the brain and the spinal cord resembled neuronal cells. The percentage of hepatocytic marker-positive cells in the iPSCs cultured on the sections of the liver was statistically higher than that of those in the iPSCs cultured on the sections of the brain and the spinal cord or on cover glasses. In contrast, the iPSCs cultured on the sections of the brain and the spinal cord revealed a high percentage of neural marker-positive cells. Thus, iPSCs can be differentiated into a specific cell lineage in response to specific factors within frozen sections of tissues/organs. Differentiation efficacy of the frozen sections markedly differed between the iPSC clones. Therefore, our induction method could be simple and effective for evaluating the iPSC quality.
Bronchioalveolar stem cells (BASCs) located at the bronchioalveolar-duct junction (BADJ) are stem cells residing in alveoli and terminal bronchioles that can self-renew and differentiate into alveolar type (AT)-1 cells, AT-2 cells, club cells, and ciliated cells. Following terminal-bronchiole injury, BASCs increase in number and promote repair. However, whether BASCs can be differentiated from mouse-induced pluripotent stem cells (iPSCs) remains unreported, and the therapeutic potential of such cells is unclear. We therefore sought to differentiate BASCs from iPSCs and examine their potential for use in the treatment of epithelial injury in terminal bronchioles. BASCs were induced using a modified protocol for differentiating mouse iPSCs into AT-2 cells. Differentiated iPSCs were intratracheally transplanted into naphthalene-treated mice. The engraftment of BASCs into the BADJ and their subsequent ability to promote repair of injury to the airway epithelium were evaluated. Flow cytometric analysis revealed that BASCs represented ~ 7% of the cells obtained. Additionally, ultrastructural analysis of these iPSC-derived BASCs via transmission electron microscopy showed that the cells containing secretory granules harboured microvilli, as well as small and immature lamellar body-like structures. When the differentiated iPSCs were intratracheally transplanted in naphthalene-induced airway epithelium injury, transplanted BASCs were found to be engrafted in the BADJ epithelium and alveolar spaces for 14 days after transplantation and to maintain the BASC phenotype. Notably, repair of the terminal-bronchiole epithelium was markedly promoted after transplantation of the differentiated iPSCs. Mouse iPSCs could be differentiated in vitro into cells that display a similar phenotype to BASCs. Given that the differentiated iPSCs promoted epithelial repair in the mouse model of naphthalene-induced airway epithelium injury, this method may serve as a basis for the development of treatments for terminal-bronchiole/alveolar-region disorders.
Taigo Horiguchi, Yumiko Miyake, Keiko Miyoshi, Ayako Tanimura, Hiroko Hagita, Hiroshi Sakaue and Takafumi Noma : Gene-expression profile reveals the genetic and acquired phenotypes of hyperactive mutant SPORTS rad, The Journal of Medical Investigation : JMI, Vol.VOL67, No.NO1,2, 51-61, 2020.
(Summary)
Spontaneously Running Tokushima Shikoku (SPORTS) rat is a hyperactive rat strain. However, the causative mutation of this phenotype has not yet been identified. To investigate the molecular basis for the unique phenotype of SPORTS rats, we examined gene-expression profiles by microarray analyses. Among adenylate kinase isozymes that maintain the homeostasis of cellular adenine nucleotide composition in the cell, only adenylate kinase 1 is highly up-regulated in both exercised and sedentary SPORTS rats compared with wild-type (WT) rats, 5.5-fold and 3.3-fold, respectively. Further comparative analyses revealed that genes involved in glucose metabolism were up-regulated in skeletal muscle tissue of exercised SPORTS rats compared with sedentary mutants, whereas genes related to extracellular matrix or region were down-regulated compared with WT rats. In brain tissue of sedentary SPORTS rats, genes associated with defense and catecholamine metabolism were highly expressed compared with WT rats. These findings suggest that genetic mutation(s) in SPORTS rat remodels metabolic demands through differentially regulating gene expression regardless of exercise. Therefore, the SPORTS rats are useful animal model not only for further examining the effects of exercise on metabolism but also for deeply studying the molecular basis how mutation affect the psychological motivation with spontaneous voluntary exercise phenotype. J. Med. Invest. 67 : 51-61, February, 2020.
Ayako Tanimura, Keiko Miyoshi, Taigo Horiguchi, Hiroko Hagita, Koichi Fujisawa and Takafumi Noma : Mitochondrial Activity and Unfolded Protein Response are Required for Neutrophil Differentiation., Cellular Physiology and Biochemistry, Vol.47, No.5, 1936-1950, 2018.
(Summary)
In this study, we demonstrated that neutrophil differentiation is regulated by ER stress/UPR that is supported by mitochondrial ATP supply, in which IRE1-XBP1 activation is essential. Our findings provide the evidence that mitochondrial energy metabolism may play a critical role in neutrophil differentiation.
Yosi Dian Arinawati, Keiko Miyoshi, Ayako Tanimura, Taigo Horiguchi, Hiroko Hagita and Takafumi Noma : Deciphering defective amelogenesis using invitro culture systems., Journal of Bioscience and Bioengineering, Vol.125, No.Issue 4, 365-496, 2018.
(Summary)
The conventional two-dimensional (2D) in vitro culture system is frequently used to analyze the gene expression with or without extracellular signals. However, the cells derived from primary culture and cell lines frequently deviate the gene expression profile compared to the corresponding in vivo samples, which sometimes misleads the actual gene regulation in vivo. To overcome this gap, we developed the comparative 2D and 3D in vitro culture systems and applied them to the genetic study of amelogenesis imperfecta (AI) as a model. Recently, we found specificity protein 6 (Sp6) mutation in an autosomal-recessive AI rat that was previously named AMI. We constructed 3D structure of ARE-B30 cells (AMI-derived rat dental epithelial cells) or G5 (control wild type cells) combined with RPC-C2A cells (rat pulp cell line) separated by the collagen membrane, while in 2D structure, ARE-B30 or G5 was cultured with or without the collagen membrane. Comparative analysis of amelogenesis-related gene expression in ARE-B30 and G5 using our 2D and 3D in vitro systems revealed distinct expression profiles, showing the causative outcomes. Bone morphogenetic protein 2 and follistatin were reciprocally expressed in G5, but not in ARE-B30 cells. All-or-none expression of amelotin, kallikrein-related peptidase 4, and nerve growth factor receptor was observed in both cell types. In conclusion, our in vitro culture systems detected the phenotypical differences in the expression of the stage-specific amelogenesis-related genes. Parallel analysis with 2D and 3D culture systems may provide a platform to understand the molecular basis for defective amelogenesis caused by Sp6 mutation.
A Adiningrat, Ayako Tanimura, Keiko Miyoshi, Hiroko Hagita, RD Yanuaryska, Arinawati Yosi Dian, Taigo Horiguchi and Takafumi Noma : Isolation and characterization of dental epithelial cells derived from amelogenesis imperfecta rat., Oral Diseases, Vol.22, No.2, 132-139, 2016.
(Summary)
OBJECTIVE:Disruption of the third zinc finger domain of specificity protein 6 (SP6) presents an enamel-specific defect in a rat model of amelogenesis imperfecta (AMI rats). To understand the molecular basis of amelogenesis imperfecta caused by the Sp6 mutation, we established and characterized AMI-derived rat dental epithelial (ARE) cells.MATERIALS AND METHODS:ARE cell clones were isolated from the mandibular incisors of AMI rats, and amelogenesis-related gene expression was analyzed by reverse transcription polymerase chain reaction (RT-PCR). Localization of wild-type SP6 (SP6WT) and mutant-type SP6 (SP6AMI) was analyzed by immunocytochemistry. SP6 transcriptional activity was monitored by rho-associated protein kinase 1 (Rock1) promoter activity with its specific binding to the promoter region in dental (G5 and ARE) and non-dental (COS-7) epithelial cells.RESULTS:Isolated ARE cells were varied in morphology and gene expression. Both SP6WT and SP6AMI were mainly detected in nuclei. The promoter analysis revealed that SP6WT and SP6AMI enhanced Rock1 promoter activity in G5 cells but that enhancement by SP6AMI was weaker, whereas no enhancement was observed in the ARE and COS-7 cells, even though SP6WT and SP6AMI bound to the promoter in all instances.CONCLUSION:ARE cell clones can provide a useful in vitro model to study the mechanism of SP6-mediated amelogenesis imperfecta.
(Keyword)
Sp6 mutation / amelogenesis imperfecta / in vitro disease model / tooth phenotype
Keiko Miyoshi, Taigo Horiguchi, Ayako Tanimura, Hiroko Hagita and Takafumi Noma : Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells., BioMed Research International, Vol.2015, 121575, 2015.
(Summary)
Oral mucosa is a useful material for regeneration therapy with the advantages of its accessibility and versatility regardless of age and gender. However, little is known about the molecular characteristics of oral mucosa. Here we report the first comparative profiles of the gene signatures of human oral mucosa fibroblasts (hOFs), human dermal fibroblasts (hDFs), and hOF-derived induced pluripotent stem cells (hOF-iPSCs), linking these with biological roles by functional annotation and pathway analyses. As a common feature of fibroblasts, both hOFs and hDFs expressed glycolipid metabolism-related genes at higher levels compared with hOF-iPSCs. Distinct characteristics of hOFs compared with hDFs included a high expression of glycoprotein genes, involved in signaling, extracellular matrix, membrane, and receptor proteins, besides a low expression of HOX genes, the hDFs-markers. The results of the pathway analyses indicated that tissue-reconstructive, proliferative, and signaling pathways are active, whereas senescence-related genes in p53 pathway are inactive in hOFs. Furthermore, more than half of hOF-specific genes were similarly expressed to those of hOF-iPSC genes and might be controlled by WNT signaling. Our findings demonstrated that hOFs have unique cellular characteristics in specificity and plasticity. These data may provide useful insight into application of oral fibroblasts for direct reprograming.
Hiroshi Kondo, Keiko Miyoshi, Shoji Sakiyama, Akira Tangoku and Takafumi Noma : Differential Regulation of Gene Expression of Alveolar Epithelial Cell Markers in Human Lung Adenocarcinoma-Derived A549 Clones, Stem Cells International, Vol.2015, 165867, 2015.
(Summary)
Stem cell therapy appears to be promising for restoring damaged or irreparable lung tissue. However, establishing a simple and reproducible protocol for preparing lung progenitor populations is difficult because the molecular basis for alveolar epithelial cell differentiation is not fully understood. We investigated an in vitro system to analyze the regulatory mechanisms of alveolus-specific gene expression using a human alveolar epithelial type II (ATII) cell line, A549. After cloning A549 subpopulations, each clone was classified into five groups according to cell morphology and marker gene expression. Two clones (B7 and H12) were further analyzed. Under serum-free culture conditions, surfactant protein C (SPC), an ATII marker, was upregulated in both H12 and B7. Aquaporin 5 (AQP5), an ATI marker, was upregulated in H12 and significantly induced in B7. When the RAS/MAPK pathway was inhibited, SPC and thyroid transcription factor-1 (TTF-1) expression levels were enhanced. After treatment with dexamethasone (DEX), 8-bromoadenosine 3'5'-cyclic monophosphate (8-Br-cAMP), 3-isobutyl-1-methylxanthine (IBMX), and keratinocyte growth factor (KGF), surfactant protein B and TTF-1 expression levels were enhanced. We found that A549-derived clones have plasticity in gene expression of alveolar epithelial differentiation markers and could be useful in studying ATII maintenance and differentiation.
Ryna Dwi Yanuaryska, Keiko Miyoshi, Arya Adiningrat, Taigo Horiguchi, Ayako Tanimura, Hiroko Hagita and Takafumi Noma : Sp6 regulation of Rock1 promoter activity in dental epithelial cells, The Journal of Medical Investigation : JMI, Vol.VOL61, No.(NO 3,4), 306-317, 2014.
(Summary)
Sp6 is a transcription factor of the SP/KLF family and an indispensable regulator of the morphological dynamics of ameloblast differentiation during tooth development. However, the underlying molecular mechanisms remain unclear. We have previously identified one of the Sp6 downstream genes, Rock1, which is involved in ameloblast polarization. In this study, we investigated the transcriptional regulatory mechanisms of Rock1 by Sp6. First, we identified the transcription start sites (TSS) and cloned the 5'-flanking region of Rock1. Serial deletion analyses identified a critical region for Rock1 promoter activity within the 249-bp upstream region of TSS, and chromatin immunoprecipitation assays revealed Sp6-binding to this region. Subsequent transient transfection experiments showed that Rock1 promoter activity is enhanced by Sp6, but reduced by Sp1. Treatment of dental epithelial cells with the GC-selective DNA binding inhibitor, mithramycin A, affected Rock1 promoter activity in loss of enhancement by Sp6, but not repression by Sp1. Further site-directed mutagenesis indicated that the region from -206 to -150 contains responsive elements for Sp6. Taken together, we conclude that Sp6 positively regulates Rock1 transcription by direct binding to the Rock1 promoter region from -206 to -150, which functionally distinct from Sp1.
Ayako Tanimura, Taigo Horiguchi, Keiko Miyoshi, Hiroko Hagita and Takafumi Noma : Differential expression of adenine nucleotide converting enzymes in mitochondrial intermembrane space: a potential role of adenylate kinase isozyme 2 in neutrophil differentiation., PLoS ONE, Vol.9, No.2, e89916, 2014.
(Summary)
Adenine nucleotide dynamics in the mitochondrial intermembrane space (IMS) play a key role in oxidative phosphorylation. In a previous study, Drosophila adenylate kinase isozyme 2 (Dak2) knockout was reported to cause developmental lethality at the larval stage in Drosophila melanogaster. In addition, two other studies reported that AK2 is a responsible gene for reticular dysgenesis (RD), a human disease that is characterized by severe combined immunodeficiency and deafness. Therefore, mitochondrial AK2 may play an important role in hematopoietic differentiation and ontogenesis. Three additional adenine nucleotide metabolizing enzymes, including mitochondrial creatine kinases (CKMT1 and CKMT2) and nucleoside diphosphate kinase isoform D (NDPK-D), have been found in IMS. Although these kinases generate ADP for ATP synthesis, their involvement in RD remains unclear and still an open question. In this study, mRNA and protein expressions of these mitochondrial kinases were firstly examined in mouse ES cells, day 8 embryos, and 7-week-old adult mice. It was found that their expressions are spatiotemporally regulated, and Ak2 is exclusively expressed in bone marrow, which is a major hematopoietic tissue in adults. In subsequent experiments, we identified increased expression of both AK2 and CKMT1 during macrophage differentiation and exclusive production of AK2 during neutrophil differentiation using HL-60 cells as an in vitro model of hematopoietic differentiation. Furthermore, AK2 knockdown specifically inhibited neutrophil differentiation without affecting macrophage differentiation. These data suggest that AK2 is indispensable for neutrophil differentiation and indicate a possible causative link between AK2 deficiency and neutropenia in RD.
Arya Adiningrat, Ayako Tanimura, Keiko Miyoshi, Ryna Yanuaryska Dwi, Hiroko Hagita, Taigo Horiguchi and Takafumi Noma : Ctip2-mediated Sp6 transcriptional regulation in dental epithelium-derived cells., The Journal of Medical Investigation : JMI, Vol.61, No.1.2, 126-136, 2014.
(Summary)
Tooth development relies on the interaction between the oral ectoderm and underlying mesenchyme, and is regulated by a complex genetic cascade. This transcriptional cascade is regulated by the spatiotemporal activation and deactivation of transcription factors. The specificity proteins 6 (Sp6) and chicken ovalbumin upstream promoter transcription factor-interacting protein 2 (Ctip2) were identified in loss-of-function studies as key transcription factors required for tooth development. Ctip2 binds to the Sp6 promoter in vivo; however, its role in Sp6 expression remains unclear. In this study, we investigated Sp6 transcriptional regulation by Ctip2. Immunohistochemical analysis revealed that Sp6 and Ctip2 colocalize in the rat incisor during tooth development. We examined whether Ctip2 regulates Sp6 promoter activity in dental epithelial cells. Cotransfection experiments using serial Sp6 promoter-luciferase constructs and Ctip2 expression plasmids showed that Ctip2 significantly suppressed the Sp6 second promoter activity, although the Sp6 first promoter activity was unaffected. Ctip2 was able to bind to the proximal region of the Sp6 first promoter, as previously demonstrated, and also to the novel distal region of the first, and second promoter regions. Our findings indicate that Ctip2 regulates Sp6 gene expression through direct binding to the Sp6 second promoter region. J. Med. Invest. 61: 126-136, February, 2014.
Taigo Horiguchi, Miyuki Fuka, Koichi Fujisawa, Ayako Tanimura, Keiko Miyoshi, Ryutaro Murakami and Takafumi Noma : Adenylate kinase 2 deficiency limits survival and regulates various genes during larval stages of Drosophila melanogaster., The Journal of Medical Investigation : JMI, Vol.61, No.1.2, 137-150, 2014.
(Summary)
Adenylate kinase isozyme 2 (AK2) is located in mitochondrial intermembrane space and regulates energy metabolism by reversibly converting ATP and AMP to 2 ADPs. We previously demonstrated that disruption of the Drosophila melanogaster AK2 gene (Dak2) resulted in growth arrest during the larval stage and subsequent death. Two other groups found that human AK2 mutations cause reticular dysgenesis, a form of severe combined immunodeficiency (SCID) that is associated with severe hematopoietic defects and sensorineural deafness. However, the mechanisms underlying differential outcomes of AK2 deficiency in Drosophila and human systems remain unknown. In this study, effects of tissue-specific inactivation of the Dak2 gene on Drosophila development were analyzed using RNAi-mediated gene knockdown. In addition, to investigate the roles of AK2 in the regulation of gene expression during development, microarray analysis was performed using RNA from first and second instar larvae of Dak2-deficient mutant and wild-type D. melanogaster. Knockdown of Dak2 in all germ layers caused cessation of growth and subsequent death of flies. Microarray analysis revealed that Dak2 deficiency downregulates various genes, particularly those involved in the proteasomal function and in mitochondrial translation machinery. These data indicate that adenine nucleotide interconversion by Dak2 is crucial for developmental processes of Drosophila melanogaster. J. Med. Invest. 61: 137-150, February, 2014.
Taro Muto, Keiko Miyoshi, Taigo Horiguchi, Hiroko Hagita and Takafumi Noma : Novel genetic linkage of rat Sp6 mutation to Amelogenesis imperfecta, Orphanet Journal of Rare Diseases, Vol.7, No.1, 2012.
(Summary)
ABSTRACT: BACKGROUND: Amelogenesis imperfecta (AI) is an inherited disorder characterized by incomplete formation of tooth enamel. Although several genes responsible for AI have been reported, not all causative genes for human AI have been identified to date. AMI rat has been reported as an autosomal recessive mutant with hypoplastic AI isolated from a colony of stroke-prone spontaneously hypertensive rat strain, but the causative gene has not yet been clarified. Through a genetic screen, we identified the causative gene of autosomal recessive AI in AMI and analyzed its role in amelogenesis. METHODS: cDNA sequencing of possible AI-candidate genes so far identified using total RNA of day 6 AMI rat molars identified a novel responsible mutation in specificity protein 6 (Sp6). Genetic linkage analysis was performed between Sp6 and AI phenotype in AMI. To understand a role of SP6 in AI, we generated the transgenic rats harboring Sp6 transgene in AMI (Ami/Ami + Tg). Histological analyses were performed using the thin sections of control rats, AMI, and Ami/Ami + Tg incisors in maxillae, respectively. RESULTS: We found the novel genetic linkage between a 2-bp insertional mutation of Sp6 gene and the AI phenotype in AMI rats. The position of mutation was located in the coding region of Sp6, which caused frameshift mutation and disruption of the third zinc finger domain of SP6 with 11 cryptic amino acid residues and a stop codon. Transfection studies showed that the mutant protein can be translated and localized in the nucleus in the same manner as the wild-type SP6 protein. When we introduced the CMV promoter-driven wild-type Sp6 transgene into AMI rats, the SP6 protein was ectopically expressed in the maturation stage of ameloblasts associated with the extended maturation stage and the shortened reduced stage without any other phenotypical changes. CONCLUSION: We propose the addition of Sp6 mutation as a new molecular diagnostic criterion for the autosomal recessive AI pateints. Our findings expand the spectrum of genetic causes of autosomal recessive AI and sheds light on the molecular diagnosis for the classification of AI. Furthermore, tight regulation of the temporospatial expression of SP6 may have critical roles in completing amelogenesis. .
Taro Muto, Keiko Miyoshi, Taigo Horiguchi and Takafumi Noma : Dissection of morphological and metabolic differentiation of amelobrasts via ectopic SP6 expression, The Journal of Medical Investigation : JMI, Vol.59, No.1-2, 59-68, 2012.
(Summary)
Tooth enamel is the hardest organ in the body. In rodent incisor, the enamel is exclusively produced by ameloblasts with yellowish-brown pigmentation, indicating normal enamel formation. However, the molecular mechanisms of ameloblast differentiation and amelogenesis are not fully understood. Specificity protein (Sp) 6 has been reported as one of the critical factors for tooth development. To explore SP6 function, we generated Sp6 transgenic (Tg) rats. Unexpectedly, the enamel surfaces of the incisors in Tg rats were discolored, even though enamel formation and serum iron concentrations were normal. Histological analysis of incisors from 6-week-old Tg rats demonstrated that the ameloblast layer at the pigmentation stage was elongated up to the gingival margin with ectopic SP6 expression in longitudinal incisor sections. In contrast, the incisors from 10-week-old Tg rats revealed that the pigmented ameloblasts were morphologically changed to those of the reduced stage, concomitant with the sporadic disappearance of ectopic SP6 expression. Here we report that morphological differentiation and metabolism of the iron-containing pigment in ameloblasts are independently regulated during amelogenesis by means of ectopic SP6 expression.
W Trianna Utami, Keiko Miyoshi, Hiroko Hagita, Dwi Ryna Yanuaryska, Taigo Horiguchi and Takafumi Noma : Possible Linkage of SP6 Transcriptional Activity with Amelogenesis by Protein Stabilization., Journal of Biomedicine & Biotechnology, Vol.2011, 2011.
(Summary)
Ameloblasts produce enamel matrix proteins such as amelogenin, ameloblastin, and amelotin during tooth development. The molecular mechanisms of ameloblast differentiation (amelogenesis) are currently not well understood. SP6 is a transcription factor of the Sp/KLF family that was recently found to regulate cell proliferation in a cell-type-specific manner. Sp6-deficient mice demonstrate characteristic tooth anomalies such as delayed eruption of the incisors and supernumerary teeth with disorganized amelogenesis. However, it remains unclear how Sp6 controls amelogenesis. In this study, we used SP6 high producer cells to identify SP6 target genes. Based on the observations that long-term culture of SP6 high producer cells reduced SP6 protein expression but not Sp6 mRNA expression, we found that SP6 is short lived and specifically degraded through a proteasome pathway. We established an in vitro inducible SP6 expression system coupled with siRNA knockdown and found a possible linkage between SP6 and amelogenesis through the regulation of amelotin and Rock1 gene expression by microarray analysis. Our findings suggest that the regulation of SP6 protein stability is one of the crucial steps in amelogenesis.
Trianna W Utami, Keiko Miyoshi, Hiroko Hagita, Ryna D. Yanuaryska, Taigo Horiguchi and Takafumi Noma : Dynamic changes of Sp6 Transgene Expression in Dental Epithelial Cells during Long-term Culture, The Indonesian Journal of Dental Research, Vol.1, No.3, 2011.
Dai Chida, Keiko Miyoshi, Tsuyoshi Sato, Tetsuya Yoda, Takefumi Kikusui and Yoichiro Iwakura : The role of glucocorticoids in pregnancy, parturition, lactation, and nurturing in melanocortin receptor 2-deficient mice., Endocrinology, Vol.152, No.4, 1652-1660, 2011.
(Summary)
Maternal glucocorticoids are critical for fetal development, but overexpression can be deleterious. Previously we established a mouse line deficient in melanocortin receptor 2 (MC2R). MC2R(-/-) mice have undetectable levels of corticosterone despite high levels of ACTH and defects resembling those in patients with familial glucocorticoid deficiency. Here we analyzed the role of glucocorticoids in pregnancy, parturition, lactation, and nurturing in MC2R(-/-) mice. MC2R(-/-) mice were fertile and produced normal litters when crossed with MC2R(+/+) mice. However, MC2R(-/-) females crossed with MC2R(-/-) males had no live births, and approximately 20% of the embryos at d 18.5 of pregnancy were of normal body size but were dead when born. MC2R(-/-) pregnant females crossed with MC2R(+/+) males had detectable serum corticosterone levels, suggesting the transplacental passage of corticosterone from fetus to mother. MC2R(+/-) pups delivered from MC2R(-/-) females crossed with MC2R(+/+) males mice thrived poorly with MC2R(-/-) mothers but grew to adulthood when transferred to foster mothers after birth, suggesting that MC2R(-/-) females are poor mothers or cannot nurse. MC2R(-/-) females had normal alveoli, but penetration of mammary epithelium into fat pads and expression of milk proteins were reduced. Myoepithelial cells, which force milk out of the alveoli, were fully developed and differentiated. Pup retrieval behavior was normal in MC2R(-/-) mice. Exogenous corticosterone rescued expression of milk proteins in MC2R(-/-) mothers, and the pups of treated mothers grew to adulthood. Our results reveal the importance of glucocorticoids for fetal survival late in pregnancy, mammary gland development, and milk protein gene expression.
Ivan Arie Wahyudi, Taigo Horiguchi, Keiko Miyoshi, Taro Muto, Trianna Wahyu Utami, Hiroko Hagita and Takafumi Noma : Isolation and Characterization of Mouse Specificity Protein 6 Promoter, The Indonesian Journal of Dental Research, Vol.2010, Volume 1, No.1, 21-34, 2010.
(Summary)
Specificity protein 6 (SP6) is a member of the SP/Krüppel-like transcription factor family and plays key roles in tooth development. To study its biological roles, it is important to understand the spatiotemporal regulation of Sp6 gene expression. For this purpose, we first identified two separate 5' ends of the Sp6 cDNA by 5' RACE analysis using mouse mandibular RNA. Next, we isolated mouse genomic DNA fragments covering the Sp6 gene including two putative mouse Sp6 promoter regions and generated a series of luciferase reporter constructs. We confirmed the activity of both promoters by a luciferase assay and found strong second promoter activity in dental epithelial cells. Unexpectedly, we also detected potential third promoter activity in the intron 2 of the Sp6 gene. Last, we also found that bone morphogenetic protein and wingless signals could enhance Sp6 promoter activity in dental epithelial cells, suggesting the regulatory roles of two cytokines in Sp6 gene expression during tooth development. Our findings may shed new light on the regulatory mechanisms of Sp6 gene expression and provide a possible linkage between cytokine regulation of Sp6 expression and inductive epithelial and mesenchymal interactions.
Keiko Miyoshi, Daisuke Tsuji, Keiko Kudoh, Kazuhito Satomura, Taro Muto, Kouji Itou and Takafumi Noma : Generation of human induced pluripotent stem cells from oral mucosa, Journal of Bioscience and Bioengineering, Vol.110, No.3, 345-350, 2010.
(Summary)
Induced pluripotent stem (iPS) cells are one of the most promising sources for cell therapy in regenerative medicine. Using a patient's own genetically identical and histocompatible cells is the ideal way to practice personalized regenerative medicine. For personalized iPS cell therapy, the prerequisites for cell source preparation are a simple and safe procedure, no aesthetic or functional damage, and quick wound healing. Oral mucosa fibroblasts (OFs) may have high potential to fulfill these requirements. In this study, biopsy was performed in a dental chair; no significant incisional damage was recognized and rapid wound healing (within a week) was observed. We generated human iPS cells from the isolated OFs via the retroviral gene transfer of OCT4, SOX2, c-MYC, and KLF4. Reprogrammed cells showed ES-like morphology and expressed undifferentiated markers such as OCT4, NANOG, SSEA4, TRA-1-60, and TRA-1-81. Subsequent in vitro and in vivo analyses confirmed the pluripotency of resultant iPS cells, which matched the criteria for iPS cells. In addition, we found that the endogenous expression levels of c-MYC and KLF4 in OFs were similar to those in dermal fibroblasts. Taken together, we propose that OFs could be a practical source for preparing iPS cells to achieve personalized regenerative medicine in the near future.
Keiko Miyoshi, Hideya Nagata, Taigo Horiguchi, Kaori Abe, Ivan Wahyudi Arie, Yoshinobu Baba, Hidemitsu Harada and Takafumi Noma : BMP2-induced gene profiling in dental epithelial cell line., The Journal of Medical Investigation : JMI, Vol.55, No.3-4, 216-226, 2008.
(Summary)
Tooth development is regulated by epithelial-mesenchymal interactions and their reciprocal molecular signaling. Bone morphogenetic protein 2 (BMP2) is known as one of the inducers for tooth development. To analyze the molecular mechanisms of BMP2 on ameloblast differentiation (amelogenesis), we performed microarray analyses using rat dental epithelial cell line, HAT-7. After confirming that BMP2 could activate the canonical BMP-Smads signaling in HAT-7 cells, we analyzed the effects of BMP2 on 14,815 gene expressions and profiled them. Seventy-three genes were up-regulated and 28 genes were down-regulated by BMP2 treatment for 24 hours in HAT-7 cells. Functional classification revealed that 18% of up-regulated genes were ECM/adhesion molecules present in the enamel organ. Furthermore, we examined the expression of several differentiation markers in dental epithelial four cell-lineages including inner enamel epithelium (ameloblasts), stratum intermedium, stratum reticulum, and outer enamel epithelium. The results indicated that BMP2 might induce at least two different cell-lineage markers including a BMP antagonist expressed in HAT-7 cells, suggesting that BMP2 could accelerate amelogenesis via BMP signaling.
(Keyword)
Ameloblasts / Amelogenesis / Animals / Base Sequence / Bone Morphogenetic Protein 2 / Cell Line / DNA Primers / Down-Regulation / Epithelial Cells / Gene Expression Profiling / Oligonucleotide Array Sequence Analysis / Rats / Reverse Transcriptase Polymerase Chain Reaction / Signal Transduction / Smad Proteins / Up-Regulation
Intan Ruspita, Keiko Miyoshi, Taro Muto, Kaori Abe, Taigo Horiguchi and Takafumi Noma : Sp6 downregulation of follistatin gene expression in ameloblasts., The Journal of Medical Investigation : JMI, Vol.55, No.1-2, 87-98, 2008.
(Summary)
Sp6 is a member of the Sp family of transcription factors that regulate a wide range of cellular functions, such as cell growth and differentiation. Sp6, also called epiprofin, is specifically expressed in tooth germ, limb bud, and hair follicle, but there is little information on its function.To investigate the possible role of Sp6 in tooth development, first we established an Sp6-overproducing clone, CHA9, and analyzed the features of the cell, including cell proliferation and gene expression. The parental cells of CHA9 are the ameloblast-lineage G5 cells that we previously established from rat dental epithelia of lower incisor. Sp6 overproduction accelerated cell proliferation and induced the expression of ameloblastin mRNA, a marker of ameloblast differentiation. Second, we performed genome-wide screening of Sp6 target genes by microarray analysis. Out of a total 20,450 genes, 448 genes were up-regulated and 500 genes were down-regulated by Sp6. We found the expression of follistatin, a BMP antagonist, to be 22.4-fold lower in CHA9 than in control cells. Transfection of the Sp6-antisense construct into CHA9 cells restored follistatin expression back to equivalent levels seen in control cells, indicating that Sp6 regulates follistatin gene expression in ameloblasts.Our findings demonstrate that the follistatin gene is one of the Sp6 target genes in ameloblasts and suggest that Sp6 promotes amelogenesis through inhibition of follistatin gene expression.
Taro Muto, Keiko Miyoshi, Seiichi Munesue, Hiroshi Nakada, Minoru Okayama, Takashi Matsuo and Takafumi Noma : Differential expression of syndecan isoforms during mouse incisor amelogenesis., The Journal of Medical Investigation : JMI, Vol.54, No.3-4, 331-339, 2007.
(Summary)
Syndecans are transmembranous heparan sulfate proteoglycans (HSPGs) with covalently attached glycosaminoglycan side-chains located on the cell surface. The mammalian syndecan family is composed of four types of syndecans (syndecan-1 to -4). Syndecans interact with the intracellular cytoskeleton through the cytoplasmic domains of their core proteins and membrane proteins, extracellular enzymes, growth factors, and matrix components, through their heparan-sulfate chains, to regulate developmental processes.Here, as a first step to assess the possible roles of syndecan proteins in amelogenesis, we examined the expression patterns of all syndecan isoforms in continuously growing mouse incisors, in which we can overview major differentiation stages of amelogenesis at a glance. Understanding the expression domain of each syndecan isoform during specific developmental stages seems useful for investigating their physiological roles in amelogenesis. Immunohistochemical analysis of syndecan core proteins in the lower incisors from postnatal day 1 mice revealed spatially and temporally specific expression patterns, with syndecan-1 expressed in undifferentiated epithelial and mesenchymal cells, and syndecan-2, -3, and -4 in more differentiated cells. These findings suggest that each syndecan isoform functions distinctly during the amelogenesis of the incisors of mice.
Kaori Abe, Keiko Miyoshi, Taro Muto, Ruspita Intan, Taigo Horiguchi, Toshihiko Nagata and Takafumi Noma : Establishment and characterization of rat dental epithelial derived ameloblast-lineage clones., Journal of Bioscience and Bioengineering, Vol.103, No.5, 479-485, 2007.
(Summary)
Teeth are the hardest tissues covered with enamel produced by ameloblasts. The ameloblast differentiation is controlled by sequential epithelial-mesenchymal interactions during tooth morphogenesis. However, the molecular mechanism of ameloblast differentiation remains unclear. To address this question, we developed an in vitro assay system to evaluate the molecular mechanism of amelogenesis. First, we established dental epithelium-derived clones from 6-day-old rat incisors and established that cells of the clone SRE-G5 were the largest producers of amelogenin mRNA. Next, we analyzed the effects of several chemicals on the amelogenin expression in SRE-G5 cells. Only mitogen-activated protein kinase (MAPK) activators enhanced amelogenin mRNA expression. This finding corresponded to the immunohistochemical data showing the presence of phosphorylated forms of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK) during ameloblast differentiation. To examine the roles of MAPK signals, we compared the effects of anisomycin and sodium salicylate on the expression of tooth-related differentiation markers. Both anisomycin and sodium salicylate induced amelogenin, Abcg2, and Bmp4 mRNA and down-regulated p75NGFR mRNA. On the other hand, ALP, ectodin, Bmp2 and Fgf8 mRNA were up-regulated only by anisomycin. These results indicate that MAPK signaling functions, at least in part, as the inducer of ameloblast differentiation.
Thrombospondin 1 (TSP1) is a multifunctional extracellular glycoprotein present mainly in the fetal and adult skeleton. Although an inhibitory effect of TSP1 against pathological mineralization in cultured vascular pericytes has been shown, its involvement in physiological mineralization by osteoblasts is still unknown. To determine the role of TSP1 in biomineralization, mouse osteoblastic MC3T3-E1 cells were cultured in the presence of antisense phosphorothioate oligodeoxynucleotides complementary to the TSP1 sequence. The 18- and 24-mer antisense oligonucleotides caused concentration-dependent increases in the number of mineralized nodules, acid-soluble calcium deposition in the cell/matrix layer, and alkaline phosphatase activity within 9 days, without affecting cell proliferation. The corresponding sense or scrambled oligonucleotides did not affect these parameters. In the antisense oligonucleotide-treated MC3T3-E1 cells, thickened extracellular matrix, well-developed cell processes, increased intracellular organelles, and collagen fibril bundles were observed. On the other hand, the addition of TSP1 to the culture decreased the production of a mineralized matrix by MC3T3-E1 cells. Furthermore, MC3T3-E1 clones overexpressing mouse TSP1 were established and assayed for TSP1 protein and their capacity to mineralize. TSP1 dose-dependently inhibited mineralization by these cells both in vitro and in vivo. These results indicate that TSP1 functions as an inhibitory regulator of bone mineralization and matrix production by osteoblasts to sustain bone homeostasis.
Akemichi Ueno, Kikuji Yamashita, Keiko Miyoshi, Taigo Horiguchi, Intan Ruspita, Kaori Abe and Takafumi Noma : Soluble matrix from osteoblastic cells induces mineralization by dental pulp cells, The Journal of Medical Investigation : JMI, Vol.53, No.3-4, 297-302, 2006.
(Summary)
Dental pulp cells have a capacity to differentiate into mineralization-inducing cells. To clarify the molecular mechanism, we established an in vitro mineralization-inducing system by rat clonal dental pulp cell line, RPC-C2A, and tried to purify a mineralization-inducing factor in conditioned medium (CM) from pre-osteoblastic MC3T3-E1 cells. The active factor was impermeable to an ultrafiltration membrane, and sedimented by ultracentrifugation. The sedimented factor was found as a needle-like structure about 1.3 microm in average length as observed by transmission electron microscopy. The factor contained type I collagen, suggesting not a matrix vesicle, but a soluble matrix. The mineralization-inducing activity was also detected in CM from primary culture of rat calvaria (RC) cells. These results suggested that the soluble matrices from osteoblastic cells serve, at least in part, as differentiation-inducing agents.
(Keyword)
Animals / Calcification, Physiologic / Cell Line / Collagen Type I / Dental Pulp / extracellular matrix / Extracellular Matrix Proteins / Osteoblasts / Osteogenesis / Rats / Skull
Fabienne Provost Le, Keiko Miyoshi, Jean-Luc Vilotte, Brian Bierie, W Gertraud Robinson and Lothar Hennighausen : SOCS3 promotes apoptosis of mammary differentiated cells., Biochemical and Biophysical Research Communications, Vol.338, No.4, 1696-1701, 2005.
(Summary)
Growth and function of the mammary gland is regulated by cytokines and modulated by suppressor of cytokine signalling (SOCS) proteins. In vitro experiments demonstrated that SOCS3 can inhibit PRL induction of milk protein gene expression and STAT5 activation. We explored the SOCS3 expression pattern during mouse mammary development and its regulation by PRL and GH in wild-type and STAT5a-null mammary tissue. Our results suggest that, in vivo, PRL stimulates SOCS3 expression in stromal adipocytes, independently of STAT5a stimulation. In mammary epithelial cells, SOCS3 expression appears to be related to STAT3 activation. Together, our results are consistent with a role of SOCS3 in the mammary gland by promoting apoptosis of differentiated cells (adipocytes during gestation and epithelial cells during involution).
Yongzhi Cui, Greg Riedlinger, Keiko Miyoshi, Wei Tang, Cuiling Li, Chu-Xia Deng, W Gertraud Robinson and Lothar Hennighausen : Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation., Molecular and Cellular Biology, Vol.24, No.18, 8037-8047, 2004.
(Summary)
This study explored the functions of the signal transducers and activators of transcription 5a and 5b (referred to as Stat5 here) during different stages of mouse mammary gland development by using conditional gene inactivation. Mammary gland morphogenesis includes cell specification, proliferation and differentiation during pregnancy, cell survival and maintenance of differentiation throughout lactation, and cell death during involution. Stat5 is activated by prolactin, and its presence is mandatory for the proliferation and differentiation of mammary epithelium during pregnancy. To address the question of whether Stat5 is also necessary for the maintenance and survival of the differentiated epithelium, the two genes were deleted at different time points. The 110-kb Stat5 locus in the mouse was bracketed with loxP sites, and its deletion was accomplished by using two Cre-expressing transgenic lines. Loss of Stat5 prior to pregnancy prevented epithelial proliferation and differentiation. Deletion of Stat5 during pregnancy, after mammary epithelium had entered Stat5-mediated differentiation, resulted in premature cell death, indicating that at this stage epithelial cell proliferation, differentiation, and survival require Stat5.
Céline Bry, Karen Maass, Keiko Miyoshi, Klaus Willecke, Thomas Ott, Gertraud W Robinson and Lothar Hennighausen : Loss of connexin 26 in mammary epithelium during early but not during late pregnancy results in unscheduled apoptosis and impaired development., Developmental Biology, Vol.267, No.2, 418-429, 2004.
(Summary)
Gap junctions are intercellular channels that are formed by the protein family of connexins (Cxs). In mammary tissue, Cx26 and Cx32 are present in the secretory epithelium and Cx43 is localized in the myoepithelium. The expression of Cx26 and Cx32 is induced during pregnancy and lactation, respectively, thus suggesting unique roles for them in the functional development of the gland. The requirement for these connexins was explored using several strains of genetically altered mice: mice with an inactivated Cx32 gene, mice in which the Cx43 gene had been replaced with the Cx32 gene (Cx43KI32 mice) and mice in which the Cx26 gene was specifically ablated in mammary epithelium at different stages of development using Cre-loxP-based recombination. Normal mammary development was obtained in Cx32-null mice and in Cx43KI32 mammary tissue. In contrast, loss of Cx26 in mammary epithelium before puberty resulted in abrogated lobulo-alveolar development and increased cell death during pregnancy, which was accompanied by impaired lactation. Loss of Cx26 in mammary epithelium during the later part of pregnancy did not adversely interfere with functional mammary development. These results demonstrate that the presence of Cx26 is critical during early stages but not during the end of pregnancy when the tissue has completed functional differentiation. Cx26 is considered a tumor suppressor gene and Cx26-null mammary tissue was evaluated after five pregnancies. No hyperproliferation or hyperplasia was observed, suggesting that Cx26 does not function as a tumor suppressor.
Yasuhiro Nii, Keiko Miyoshi and Akemichi Ueno : Involvement of G protein and protein kinase C in induction of Tartrate-resistant acid phosphatase and multinucleation by 1-, 25-dihydroxyvitamin D3 in spleen cells., Journal of Clinical and Experimental Medicine, Vol.207, No.12·13, 1027-1028, 2003.
37.
Yiping Wu, Yongzhi Cui, Keiko Miyoshi, Lothar Hennighausen, Jeffrey E. Green, Jennifer Setser, Derek LeRoith and Shoshana Yakar : Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors, Cancer Research, Vol.63, No.15, 4384-4388, 2003.
(Summary)
Insulin-like growth factors (IGFs) play a crucial role in regulating cell proliferation and differentiation. The aim of this study was to examine the potential relationship between serum IGF-I levels and breast cancer risk. To do this, we studied liver-specific IGF-I gene-deleted (LID) mice, in which circulating IGF-I levels are 25% of that in control mice. Mammary tumors were induced in two ways: (a) by exposing mice to the carcinogen 7,12-dimethybenz (a)anthracene; and (b) by crossing LID mice with C3(1)/SV40 large T-antigen transgenic mice. In both models, LID mice exhibited a delayed latency period of mammary tumor development. In the 7,12-dimethybenz (a)anthracene-induced mammary tumor model, the incidence of palpable mammary tumors was significantly lower in LID mice (26% versus 56% in controls), and the onset of the tumors was delayed (74 +/- 1.2 days in LID mice versus 59.5 +/- 1.1 days in controls). Histological analysis showed extensive squamous metaplasia in late-stage mammary tumors of control mice, whereas late-stage tumors from LID mice exhibited extensive hyperplasia, but little metaplasia. In control mice, the onset of C3(1)/SV40-large T-antigen-induced mammary tumors occurred at 21.6 +/- 1.8 weeks of age, whereas in LID mice the average age of onset was 30.2 +/- 1.7 weeks. In addition, 60% of the mice in the control group developed two or more mammary tumors per mouse, whereas in the LID mice only 30% developed more than one mammary tumor per mouse. Our data demonstrate that circulating IGF-I levels play a significant role as a risk factor in the onset and development of mammary tumors in two well-established animal models of breast cancer.
Jean-Pierre Renou, Brian Bierie, Keiko Miyoshi, Yongzhi Cui, Jean Djiane, Moshe Reichenstein, Moshe Shani and Lothar Hennighausen : Identification of genes differentially expressed in mouse mammary epithelium transformed by an activated beta-catenin., Oncogene, Vol.22, No.29, 4594-4610, 2003.
(Summary)
Beta-catenin is an executor of Wnt signaling and it can control cell fate and specification. Deletion of exon 3 from the endogenous beta-catenin gene in differentiating mammary alveolar epithelium of the mouse results in the generation of an activated protein that lacks amino acids 5-80. This is accompanied by a loss of mammary epithelial differentiation and a transdifferentiation process to squamous metaplasias. To further understand the molecular process of transdifferentiation, the expression of genes in mammary tissue was profiled in the absence and presence of activated of beta-catenin. Microarrays were generated that carry about 8500 cDNA clones with approximately 6000 obtained from mammary tissue. Mutant tissues, which had undergone either partial (TD1) or complete (TD2) squamous transdifferentiation, were compared with wild-type mammary tissue. Four groups of genes were identified. Group 1 contained genes whose expression was induced in both mutant tissues. Groups 2 and 3 contained genes that were active preferentially in TD2 and TD1, respectively. Group 4 contained genes suppressed in both samples. Using this approach, known and unknown genes activated in the transdifferentiation process were identified. A new 20 kDa protein (PANE1) induced upon transdifferentiation was nuclear in nonconfluent cells and cytoplasmic in confluent or dividing cells. Lastly, stabilization of beta-catenin resulted in the retention of differentiated epithelium upon involution and altered activities of several proteases in transdifferentiated mammary epithelium.
Brian Bierie, Masahiro Nozawa, Jean-Pierre Renou, Jonathan M Shillingford, Fanta Morgan, Takami Oka, Makoto M Taketo, Robert D Cardiff, Keiko Miyoshi, Kay-Uwe Wagner, Gertraud W Robinson and Lothar Hennighausen : Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation., Oncogene, Vol.22, No.25, 3875-3887, 2003.
(Summary)
The Wnt/beta-catenin signaling pathway is critical for normal mammalian development, the specification of epidermal cells and neoplastic transformation of intestinal epithelium. However, precise molecular information regarding cell-specific responses to beta-catenin signaling has been limited. This question was addressed using a mouse model in which exon 3 of the beta-catenin gene was deleted in several cell types with loxP-mediated recombination utilizing a Cre transgene under control of the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). The stabilization of beta-catenin in prostate epithelium resulted in hyperplasias and extensive transdifferentiation into epidermal-like structures, which expressed keratins 1 and 6, filaggrin, loricrin and involucrin. The cell-specific loss of NKCC1 protein and reduced nuclear Stat5a is further suggestive of a loss of prostate epithelial characteristics. In addition to the prostate, hyperplasias and squamous metaplasias were detected in epithelia of the epididymis, vas deferens, coagulating gland, preputial gland and salivary gland. However, and in contrast to a recent study, no lesions reminiscent of high-grade prostate intraepithelial neoplasia were detected. Since beta-catenin was activated in several cell types and impinged upon the viability of these mice, it was not possible to evaluate the cumulative effect over more than 3 months. To assess long-term consequences of beta-catenin activation, mutant and control prostate tissues were transplanted into the mammary fat pads of wild-type males. Notably, squamous metaplasias, intra-acinous hyperplasia and possible neoplastic transformation were observed after a total of 18 weeks of beta-catenin stimulation. This suggests that the transdifferentiation into squamous metaplasias is an early response of endoderm-derived cells to beta-catenin, and that the development of intra-acinous hyperplasias or neoplastic foci is a later event.
Easwari Kumaraswamy, A Bradley Carlson, Fanta Morgan, Keiko Miyoshi, W Gertraud Robinson, Dan Su, Shulin Wang, Eileen Southon, Lino Tessarollo, Jae Byeong Lee, N Vadim Gladyshev, Lothar Hennighausen and L Dolph Hatfield : Selective removal of the selenocysteine tRNA[Ser]Sec gene (Trsp) in mouse mammary epithelium., Molecular and Cellular Biology, Vol.23, No.5, 1477-1488, 2003.
(Summary)
Mice homozygous for an allele encoding the selenocysteine (Sec) tRNA [Ser]Sec gene (Trsp) flanked by loxP sites were generated. Cre recombinase-dependent removal of Trsp in these mice was lethal to embryos. To investigate the role of Trsp in mouse mammary epithelium, we deleted this gene by using transgenic mice carrying the Cre recombinase gene under control of the mouse mammary tumor virus (MMTV) long terminal repeat or the whey acidic protein promoter. While both promoters target Cre gene expression to mammary epithelium, MMTV-Cre is also expressed in spleen and skin. Sec tRNA [Ser]Sec amounts were reduced by more than 70% in mammary tissue with either transgene, while in skin and spleen, levels were reduced only with MMTV-Cre. The selenoprotein population was selectively affected with MMTV-Cre in breast and skin but not in the control tissue, kidney. Moreover, within affected tissues, expression of specific selenoproteins was regulated differently and often in a contrasting manner, with levels of Sep15 and the glutathione peroxidases GPx1 and GPx4 being substantially reduced. Expression of the tumor suppressor genes BRCA1 and p53 was also altered in a contrasting manner in MMTV-Cre mice, suggesting greater susceptibility to cancer and/or increased cell apoptosis. Thus, the conditional Trsp knockout mouse allows tissue-specific manipulation of Sec tRNA and selenoprotein expression, suggesting that this approach will provide a useful tool for studying the role of selenoproteins in health.
Keiko Miyoshi and Lothar Hennighausen : Beta-catenin: a transforming actor on many stages., Breast Cancer Research, Vol.5, No.2, 63-68, 2003.
(Summary)
Mutations and deletions that result in the stabilization of beta-catenin are frequently found in a number of tumors, including those of the colon, the liver and the ovary, but are less frequently found in breast cancer. To investigate and understand the molecular nature of cell-specific beta-catenin signaling, experimental mouse genetics has been employed extensively. Gain-of-function and loss-of-function mutations have provided evidence that beta-catenin plays essential roles in development and tumorigenesis. Specifically, the Wnt/beta-catenin signaling pathway controls cell fate decisions throughout development, and a unique role in differentiated epithelia has emerged. Not only beta-catenin, but also the activation of other components of this pathway in differentiated mammary epithelium and prostate epithelium of transgenic mice can induce neoplasias and transdifferentiation to squamous metaplasias. This suggests that the Wnt/beta-catenin pathway is dominant over existing differentiation programs and can impose an epidermal fate or neoplasias onto a variety of cell types. Although there is evidence for a contextual specificity of the Wnt signaling, the experimental systems and designs used in different studies probably influence the cellular responses.
L Sandra Grimm, N Tiffany Seagroves, B Elena Kabotyanski, C Russell Hovey, K Barbara Vonderhaar, P John Lydon, Keiko Miyoshi, Lothar Hennighausen, J Christopher Ormandy, V Adrian Lee, A Malinda Stull, L Teresa Wood and M Jeffrey Rosen : Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development., Molecular Endocrinology, Vol.16, No.12, 2675-2691, 2002.
(Summary)
Targeted deletion of the bZIP transcription factor, CCAAT/enhancer binding protein-beta (C/EBPbeta), was shown previously to result in aberrant ductal morphogenesis and decreased lobuloalveolar development, accompanied by an altered pattern of progesterone receptor (PR) expression. Here, similar changes in the level and pattern of prolactin receptor (PrlR) expression were observed while screening for differentially expressed genes in C/EBPbeta(null) mice. PR patterning was also altered in PrlR(null) mice, as well as in mammary tissue transplants from both PrlR(null) and signal transducer and activator of transcription (Stat) 5a/b-deficient mice, with concomitant defects in hormone-induced proliferation. Down-regulation of PR and activation of Stat5 phosphorylation were seen after estrogen and progesterone treatment in both C/EBPbeta(null) and wild-type mice, indicating that these signaling pathways were functional, despite the failure of steroid hormones to induce proliferation. IGF binding protein-5, IGF-II, and insulin receptor substrate-1 all displayed altered patterns and levels of expression in C/EBPbeta(null) mice, suggestive of a change in the IGF signaling axis. In addition, small proline-rich protein (SPRR2A), a marker of epidermal differentiation, and keratin 6 were misexpressed in the mammary epithelium of C/EBPbeta(null) mice. Together, these data suggest that C/EBPbeta is a master regulator of mammary epithelial cell fate and that the correct spatial pattern of PR and PrlR expression is a critical determinant of hormone-regulated cell proliferation.
Keiko Miyoshi, Barbara Meyer, Peter Gruss, Yongzhi Cui, Jean-Pierre Renou, Fanta V Morgan, Gilbert H Smith, Moshe Reichenstein, Moshe Shani, Lothar Hennighausen and Gertraud W Robinson : Mammary epithelial cells are not able to undergo pregnancy-dependent differentiation in the absence of the helix-loop-helix inhibitor Id2., Molecular Endocrinology, Vol.16, No.12, 2892-2901, 2002.
(Summary)
Mammary alveolar development during pregnancy is triggered by hormone signals. The prolactin receptor/Jak2/signal transducer and activator of transcription (Stat) 5 signal transduction pathway is the principal mediator of these cues and alveolar development is abrogated in its absence. The loss of the basic helix-loop-helix protein inhibitor of differentiation (Id)2 results in a similar defect. To investigate the role of Id2 in mammary epithelium, we performed structural and molecular analyses. Id2-null mammary epithelial cells were unable to form alveoli; the epithelial architecture was disorganized and dissimilar from early stages of alveologenesis in wild-type glands. The epithelial cells retained the ductal marker Na-K-Cl cotransporter (NKCC)1. Nuclear localization of Stat5a and down-regulation of NKCC1 was observed in some areas, indicating a limited response to pregnancy signals. The differentiation status of Id2-null tissue at term was further characterized with cDNA microarrays enriched in mammary specific sequences (mammochip). Some of the early differentiation markers for mammary epithelium were expressed in the Id2-null tissue, whereas genes that are expressed at later stages of pregnancy were not induced. From these results, we conclude that, in the absence of Id2, mammary epithelial development is arrested at an early stage of pregnancy.
Andrea Rosner, Keiko Miyoshi, Esther Landesman-Bollag, Xin Xu, C David Seldin, R Amy Moser, L Carol MacLeod, G Shyamala, E Amy Gillgrass and D Robert Cardiff : Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors., The American Journal of Pathology, Vol.161, No.3, 1087-1097, 2002.
(Summary)
To study phenotype-genotype correlations, ErbB/Ras pathway tumors (transgenic for ErbB2, c-Neu, mutants of c-Neu, polyomavirus middle T antigene (PyV-mT), Ras, and bi-transgenic for ErbB2/Neu with ErbB3 and with progesterone receptor) from four different institutions were histopathologically compared with Wnt pathway tumors [transgenes Wnt1, Wnt10b, dominant-negative glycogen synthase kinase 3-beta, beta-Catenin, and spontaneous mutants of adenomatous polyposis coli gene (Apc)]. ErbB/Ras pathway tumors tend to form solid nodules consisting of poorly differentiated cells with abundant cytoplasm. ErbB/Ras pathway tumors also have scanty stroma and lack myoepithelial or squamous differentiation. In contrast, Wnt pathway tumors exhibit myoepithelial, acinar, or glandular differentiation, and, frequently, combinations of these. Squamous metaplasia is frequent and may include transdifferentiation to epidermal and pilar structures. Most Wnt pathway tumors form caricatures of elongated, branched ductules, and have well-developed stroma, inflammatory infiltrates, and pushing margins. Tumors transgenic for interacting genes such as protein kinase CK2alpha (casein kinase IIalpha), and the fibroblast growth factors (Fgf) Int2/Fgf3 or keratinocyte growth factor (Kgf/Fgf7) also have the Wnt pathway phenotype. Because the tumors from the ErbB/Ras and the Wnt pathway are so distinct and can be readily identified using routine hematoxylin and eosin sections, we suggest that pathway pathology is applicable in both basic and clinical cancer research.
Keiko Miyoshi, Andrea Rosner, Masahiro Nozawa, Christopher Byrd, Fanta Morgan, Esther Landesman-Bollag, Xin Xu, C David Seldin, V Emmett Schmidt, M Makato Taketo, W Gertraud Robinson, D Robert Cardiff and Lothar Hennighausen : Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors., Oncogene, Vol.21, No.36, 5548-5556, 2002.
(Summary)
The Wnt/beta-catenin signaling pathway controls cell fate and neoplastic transformation. Expression of an endogenous stabilized beta-catenin (DeltaE3 beta-catenin) in mammary epithelium leads to the transdifferentiation into epidermis- and pilar-like structures. Signaling molecules in the canonical Wnt pathway upstream from beta-catenin induce glandular tumors but it is not clear whether they also cause squamous transdifferentiation. To address this question we have now investigated mammary epithelium from transgenic mice that express activating molecules of the Wnt pathway: Wnt10b, Int2/Fgf3, CK2alpha, DeltaE3 beta-catenin, Cyclin D1, and dominant negative (dn) GSK3beta. Cytokeratin 5 (CK5), which is expressed in both mammary myoepithelium and epidermis, and the epidermis-specific CK1 and CK6 were used as differentiation markers. Extensive squamous metaplasias and widespread expression of CK1 and CK6 were observed in DeltaE3 beta-catenin transgenic mammary tissue. Wnt10b and Int2 transgenes also induced squamous metaplasias, but expression of CK1 and CK6 was sporadic. While CK5 expression in Wnt10b transgenic tissue was still confined to the lining cell layer, its expression in Int2 transgenic tissue was completely disorganized. In contrast, cytokeratin expression in CK2alpha, dnGSK3beta and Cyclin D1 transgenic mammary tissues was similar to that in DeltaE3 beta-catenin tissue. In support of transdifferentiation, expression of hard keratins specific for hair and nails was observed in pilar tumors. These results demonstrate that the activation of Wnt signaling components in mammary epithelium induces not only glandular tumors but also squamous differentiation, possibly by activating LEF-1, which is expressed in normal mammary epithelium.
M Jonathan Shillingford, Keiko Miyoshi, Michael Flagella, E Gary Shull and Lothar Hennighausen : Mouse mammary epithelial cells express the Na-K-Cl cotransporter, NKCC1: characterization, localization, and involvement in ductal development and morphogenesis., Molecular Endocrinology, Vol.16, No.6, 1309-1321, 2002.
(Summary)
Despite the fact that physiological evidence points to the existence of a functional Na-K-Cl cotransporter in the mammary gland, the molecular identity of this transport process remains unknown. We now show that the Na-K-Cl cotransporter isoform, NKCC1, is expressed in mammary tissue. Developmental profiling revealed that the level of NKCC1 protein was significantly influenced by the stage of mammary gland development, and immunolocalization studies demonstrated that NKCC1 was present on the basolateral membrane of mammary epithelial cells. To examine whether functional NKCC1 is required for mammary epithelial cell development, we used NKCC1 -/- mice. We demonstrate that NKCC1 -/- mammary epithelium exhibited a significant delay in ductal outgrowth and an increase in branching morphogenesis during virgin development. These effects were autonomous to the epithelium as assessed by mammary gland transplantation. Although the absence of NKCC1 had no apparent effect on gross mammary epithelial cell morphology during lactation, pups born to NKCC1 -/- mice failed to thrive. Finally, analysis of NKCC1 protein in mouse models that exhibit defects in mammary gland development demonstrate that high levels of NKCC1 protein are indicative of ductal epithelial cells, and the presence of NKCC1 protein is characteristic of mammary epithelial cell identity.
Yongzhi Cui, Keiko Miyoshi, Estefania Claudio, Ulrich K. Siebenlist, Frank J. Gonzalez, Jodi Flaws, Kay-Uwe Wagner and Lothar Hennighausen : Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility., The Journal of Biological Chemistry, Vol.277, No.20, 17830-17835, 2002.
(Summary)
The peroxisome proliferation-activated receptor gamma (PPARgamma) is expressed in many cell types including mammary epithelium, ovary, macrophages, and B- and T-cells. PPARgamma has an anti-proliferative effect in pre-adipocytes and mammary epithelial cells, and treatment with its ligands reduced the progression of carcinogen-induced mammary tumors in mice. Because PPARgamma-null mice die in utero it has not been possible to study its role in development and tumorigenesis in vivo. To investigate whether PPARgamma is required for the establishment and physiology of different cell types, a cell-specific deletion of the gene was carried out in mice using the Cre-loxP recombination system. We deleted the PPARgamma gene in mammary epithelium using WAP-Cre transgenic mice and in epithelial cells, B- and T-cells, and ovary cells using MMTV-Cre mice. The presence of PPARgamma was not required for functional development of the mammary gland during pregnancy and for the establishment of B- and T-cells. In addition, no increase in mammary tumors was observed. However, loss of the PPARgamma gene in oocytes and granulosa cells resulted in impaired fertility. These mice have normal populations of follicles, they ovulate and develop corpora lutea. Although progesterone levels are decreased and implantation rates are reduced, the exact cause of the impaired fertility remains to be determined.
M Jonathan Shillingford, Keiko Miyoshi, W Gertraud Robinson, L Sandra Grimm, M Jeffrey Rosen, Hans Neubauer, Klaus Pfeffer and Lothar Hennighausen : Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium., Molecular Endocrinology, Vol.16, No.3, 563-570, 2002.
(Summary)
The PRL receptor (PrlR) and the signal transducer and activator of transcription 5a (Stat5a) are essential for the proliferation and differentiation of mammary epithelium during pregnancy. Based on tissue culture cell experiments, Jak2 is the tyrosine kinase responsible for the phosphorylation of both the PrlR and Stat5. We have now used a genetic approach to test the role of Jak2 in the mammary gland, a PrlR-responsive tissue. Because Jak2-null embryos die at E12.5, we transplanted Jak2-null mammary anlagen into cleared fat pads of wild-type mice and investigated epithelial development during pregnancy. In the absence of Jak2, no secretory alveoli were present at parturition, and epithelial cell proliferation was reduced by 95% after an acute hormone treatment. Furthermore, the Na-K-Cl cotransporter, a ductal marker, was maintained in Jak2-null epithelium and the sodium-phosphate cotransporter type IIb, a secretory cell marker, was absent. Nuclear Stat5a was only observed in a few epithelial cells in Jak2-null glands at pregnancy and parturition compared with most epithelial cells in wild-type glands. Taken together, our results demonstrate that Jak2 is a critical tyrosine kinase that conveys intracellular signals necessary for proliferation and differentiation of mammary epithelium during pregnancy.
Gregory Riedlinger, Ryugo Okagaki, Kay-Uwe Wagner, B Edmund Rucker, Takami Oka, Keiko Miyoshi, A Jodi Flaws and Lothar Hennighausen : Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovary., Biology of Reproduction, Vol.66, No.2, 438-444, 2002.
(Summary)
It has been proposed that Bcl-x is a key survival factor in many cell types, and that the bcl-x gene is activated by the transcription factor Stat5 through cytokine signals. In support of this, it has been demonstrated that the survival of mouse primordial germ cells during embryogenesis depends on the presence of Bcl-x. We have now investigated whether, in the mouse, Bcl-x is required for the postnatal maintenance of follicles and luteal cells, and whether Stat5 activates the bcl-x gene. The bcl-x gene was deleted in these cells within the mouse using Cre-loxP recombination. Loss of the bcl-x gene did not affect the numbers of primordial, primary, and antral follicles. Furthermore, expression of the bcl-x gene in the ovary was independent of Stat5 and its activating hormone, prolactin. To determine whether the prolactin receptor (PrlR), Stat5, and Bcl-x were required for establishment and maintenance of the corpus luteum, we induced pseudopregnancies in the respective gene-deletion mice. Whereas luteal cells underwent apoptosis in the absence of the PrlR, no changes were observed in the absence of Stat5 or Bcl-x.
Keiko Miyoshi, Jonathan M Shillingford, Fabienne Provost Le, Fotini Gounari, Roderick Bronson, Harald von Boehmer, Makoto M Taketo, Robert D Cardiff, Khashayarsha Khazaie and Lothar Hennighausen : Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias., Proceedings of the National Academy of Sciences of the United States of America, Vol.99, No.1, 219-224, 2002.
(Summary)
Mammary anlagen are formed in the embryo as a derivative of the epidermis, a process that is controlled by Lef-1 and therefore possibly by beta-catenin. To investigate the role of beta-catenin signaling in mammary alveolar epithelium, we have stabilized endogenous beta-catenin in differentiating alveolar epithelium through the deletion of exon 3 (amino acids 5-80) of the beta-catenin gene. This task was accomplished in mice carrying a floxed beta-catenin gene and a Cre transgene under control of the mammary-specific whey acidic protein (WAP) gene promoter or the mouse mammary tumor virus-long terminal repeat (MMTV-LTR). Stabilized beta-catenin was obtained during the first pregnancy, and its presence resulted in the dedifferentiation of alveolar epithelium followed by a transdifferentiation into epidermal and pilar structures. Extensive squamous metaplasia, but no adenocarcinomas, developed upon beta-catenin activation during pregnancy and persisted throughout involution. These data demonstrate that the activation of beta-catenin signaling induces a program that results in loss of mammary epithelial cell differentiation and induction of epidermal structures.
D K Walton, U K Wagner, B E Rucker, M J Shillingford, Keiko Miyoshi and L Hennighausen : Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation., Mechanisms of Development, Vol.109, No.2, 281-293, 2001.
(Summary)
In the mammary gland Bcl-x is the most abundant cell survival factor from the Bcl-2 family. Since Bcl-x null mice die around day 12 of embryogenesis, the relevance of this protein in organ development and function is poorly understood. In erythroid cells bcl-x gene expression is controlled by cytokines and the transcription factor Stat5 (signal transducer and activator of transcription). However, we identified that bcl-x RNA levels in mammary tissue from prolactin receptor- and Stat5-null mice were indistinguishable from wild type mice. We have proposed that Bcl-x might control the survival of mammary epithelial cells throughout pregnancy, lactation, and the early stages of involution, and we have now tested this hypothesis through the conditional deletion of the bcl-x gene from mouse mammary epithelium. Conditional (floxed) bcl-x alleles were excised from alveolar cells during pregnancy using a Cre transgene under the control of the whey acidic protein gene promoter. Deletion of the bcl-x gene from the entire epithelial compartment (ducts and alveoli) was achieved by expressing Cre-recombinase under control of the mouse mammary tumor virus long terminal repeat. The absence of Bcl-x did not compromise proliferation and differentiation of mammary ductal and alveolar epithelial cells in virgin mice and during pregnancy and lactation. However, epithelial cell death and tissue remodeling were accelerated in the bcl-x conditional knockout mice during the first stage of involution. Concomitant deletion of the bax gene did not significantly modify the Bcl-x phenotype. Our results suggest that Bcl-x is not essential during mammopoiesis, but is critical for controlled apoptosis during the first phase of involution.
(Tokushima University Institutional Repository: 114214, PubMed: 11731240)
52.
Keiko Miyoshi, Jonathan M Shillingford, Gilbert H Smith, Sandra L Grimm, Kay-Uwe Wagner, Takami Oka, Jeffrey M Rosen, Gertraud W Robinson and Lothar Hennighausen : Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium., The Journal of Cell Biology, Vol.155, No.4, 531-542, 2001.
(Summary)
Functional development of mammary epithelium during pregnancy depends on prolactin signaling. However, the underlying molecular and cellular events are not fully understood. We examined the specific contributions of the prolactin receptor (PrlR) and the signal transducers and activators of transcription 5a and 5b (referred to as Stat5) in the formation and differentiation of mammary alveolar epithelium. PrlR- and Stat5-null mammary epithelia were transplanted into wild-type hosts, and pregnancy-mediated development was investigated at a histological and molecular level. Stat5-null mammary epithelium developed ducts but failed to form alveoli, and no milk protein gene expression was observed. In contrast, PrlR-null epithelium formed alveoli-like structures with small open lumina. Electron microscopy revealed undifferentiated features of organelles and a perturbation of cell-cell contacts in PrlR- and Stat5-null epithelia. Expression of NKCC1, an Na-K-Cl cotransporter characteristic for ductal epithelia, and ZO-1, a protein associated with tight junction, were maintained in the alveoli-like structures of PrlR- and Stat5-null epithelia. In contrast, the Na-Pi cotransporter Npt2b, and the gap junction component connexin 32, usually expressed in secretory epithelia, were undetectable in PrlR- and Stat5-null mice. These data demonstrate that signaling via the PrlR and Stat5 is critical for the proliferation and differentiation of mammary alveoli during pregnancy.
Keiko Miyoshi, Yongzhi Cui, Greg Riedlinger, Phyllis Robinson, Jessica Lehoczky, Leonard Zon, Takami Oka, Ken Dewar and Lothar Hennighausen : Structure of the mouse Stat 3/5 locus: evolution from Drosophila to zebrafish to mouse, Genomics, Vol.71, No.2, 150-155, 2001.
(Summary)
Signal transducers and activators of transcription (Stat) are transcription factors that can be activated by many cytokines. While Drosophila contains only one Stat (d-Stat), mammals contain seven, with STATs 3, 5a, and 5b being the closest functional relatives. To understand the evolutionary relationship between d-Stat and vertebrate STATs 3 and 5, we isolated, sequenced, and analyzed the zebrafish Stat3 (z-Stat3) gene and a 500-kb region spanning mouse chromosome 11, 60.5 cM containing three Stat genes (m-Stats). Within this region we identified the genes encoding m-Stats 3, 5a, and 5b, Cnp1, Hcrt/Orexin, Ptrf, GCN5, mDj11, and four new genes. The 5' ends of the m-Stat5a and m-Stat5b genes are juxtaposed to each other, and the 3' ends of the m-Stat3 and Stat5a genes face each other. While the m-Stat5a and m-Stat3 genes have one promoter each, which are active in many tissues, the m-Stat5b gene acquired two distinct promoters. The distal promoter is expressed ubiquitously, and transcription from the proximal promoter is restricted to liver, muscle, and mammary tissue. Through a comparison of exon-intron boundaries from the m-Stat3, m-Stat5a, and m-Stat5b, z-Stat3, and d-Stat genes, we deduced their evolutionary relationship. We propose that the Stat3 and Stat5 lineages are derived from the duplication of a common primordial gene and that d-Stat is a part of the Stat5 lineage.
(Keyword)
Animals / Base Sequence / Conserved Sequence / DNA-Binding Proteins / Drosophila / Evolution, Molecular / Exons / Introns / Mice / Milk Proteins / Molecular Sequence Data / Multigene Family / Protein Structure, Tertiary / RNA, Messenger / STAT3 Transcription Factor / STAT5 Transcription Factor / Sequence Analysis, DNA / Tissue Distribution / Trans-Activators / Zebrafish / Zebrafish Proteins
J Tanaka, Y Miwa, Keiko Miyoshi, A Ueno and H Inoue : Construction of Epstein-Barr virus-based expression vector containing mini-oriP., Biochemical and Biophysical Research Communications, Vol.264, No.3, 938-943, 1999.
(Summary)
Epstein-Barr virus (EBV)-based vectors are extrachromosomal vectors carrying a replicational origin, oriP (about 2200 bp) and a replication initiation factor (EBNA-1) which are sufficient for autonomous replication. Because one disadvantage of these vectors is their large sizes, we examined the effect of partial deletion of oriP on the effectiveness of the EBV-based vectors, using an enhanced green fluorescent protein (EGFP) as a reporter to monitor gene expression. Results indicated that 954 bp-deleted mini-oriP is useful in primate cells since the vector showed high efficiency of stable transfection, a high ratio of EGFP-positive cells, and high recovery of intact plasmid DNA from transfected cells.
Keiko Miyoshi : Studies on the regulation mechanism of ornithine decarboxylase activity in sialagogue-stimulated rat parotid explant., Shikoku Dental Research, Vol.11, No.1, 33-46, 1998.
56.
Y Ashida, A Ueno, Y Miwa, Keiko Miyoshi and H Inoue : Putrescine-stimulated intracellular Ca2+ release for invasiveness of rat ascites hepatoma cells., Gann : Japanese Journal of Cancer Research, Vol.89, No.1, 67-75, 1998.
(Summary)
Our previous study showed that treatment of highly invasive rat ascites hepatoma (LC-AH) cells with alpha-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, decreased both their intracellular level of putrescine and their in vitro invasion of a monolayer of calf pulmonary arterial endothelial (CPAE) cells, and that both these decreases were completely reversed by exogenous putrescine, but not spermidine or spermine. Here we show that all adhering control (DFMO-untreated) cells migrated beneath CPAE monolayer with morphological change from round to cauliflower-shaped cells (migratory cells). DFMO treatment increased the number of cells that remained round without migration (nonmigratory cells). Exogenous putrescine, but not spermidine or spermine, induced transformation of all nonmigratory cells to migratory cells with a concomitant increase in their intracellular Ca2+ level, [Ca2+]i. The putrescine-induced increase in their [Ca2+]i preceded their transformation and these effects of putrescine were not affected by antagonists of the voltage-gated Ca2+ channel, but were completely suppressed by ryanodine, which also suppressed the invasiveness of the control cells. The DFMO-induced decreases in both [Ca2+]i and the invasiveness of the cells were restored by thapsigargin, which elevated [Ca2+]i by inhibiting endoplasmic Ca2+-ATPase, indicating that thapsigargin mimics the effects of putrescine. These results support the idea that putrescine is a cofactor for Ca2+ release through the Ca2+ channel in the endoplasmic reticulum that is inhibited by ryanodine, this release being initiated by cell adhesion and being a prerequisite for tumor cell invasion.
(Tokushima University Institutional Repository: 109837)
Proceeding of International Conference:
1.
Lutfi Perdana, R Raju, Jaime Fabillar, Dara Arini, S Raman, Masamitsu Ohshima, Daisuke Ikutame, Keiko Miyoshi and Yoshizo Matsuka : Investigating the antinociceptive mechanism of ril-10: a novel therapeutic target for orofacial pain, Asian Academy of Orofacial Pain and Temporomandibular Disorders, Taipei, Nov. 2024.
2.
Keiko Miyoshi, Arinawati Yosi Dian, Hagita Hiroko, Taigo Horiguchi and Takafumi Noma : Possible roles of Sp6 in ameloblast differentiation, The 6th International Conference on Biology and Pathobiology of KLF/Sp Transcription Factors, Oct. 2018.
3.
Ayako Tanimura, Keiko Miyoshi, Taigo Horiguchi, Hagita Hiroko, Koichi Fujisawa and Takafumi Noma : A role of ER stress and UPR on hematopoietic differentiation, 51st Miami Winter Symposium, Stem Cells Todays Research Tomorrows Therapies, Miami, Jan. 2018.
4.
Arinawati Yosi Dian, Keiko Miyoshi, Ayako Tanimura, Taigo Horiguchi and Takafumi Noma : Comparative study of gene profiling using 2D and 3D culture as an in vitro amelogenesis imperfecta model, Internationl Joint meeting 4th ASEAN plus Tokushima Joint International Conference, Dec. 2017.
5.
Ayako Tanimura, Keiko Miyoshi, Taigo Horiguchi, Hagita Hiroko, Koichi Fujisawa and Takafumi Noma : Impact of mitochondrial ATP production on neutrophil differentiation, Gordon Research Conference(From Molecular Structures and Mechanisms to Cellular Bioenergetics in Health and Disease), Jun. 2017.
6.
Keiko Miyoshi, Hagita Hiroko, Arinawati Yosi Dian, Ayako Tanimura, Taigo Horiguchi and Takafumi Noma : Regulation of SP6 protein expression in stably transformed dental epithelial cells, 12th International Conference on Tooth Morphogenesis and Differentiation, Porvoo,Finland, Jun. 2016.
7.
Keiko Miyoshi, Adiningrat Arya, Ayako Tanimura, Yanuaryska Dwi Ryna, Arinawati Yosi Dian, Taigo Horiguchi and Takafumi Noma : Establishment of an in Vitro amelogenesis imperfecta model, Challenge to Intractable Oral Diseases International Symposium 2015 which takes place at Yumikura Hall,Osaka University Graduate School of Dentistry in Japan from 10-11 December 2015, Dec. 2015.
(Keyword)
amelogenesis imperfecta / ARE / in vitro model / SP6 / structure-activity relationship
8.
Taigo Horiguchi, Keiko Miyoshi, Ayako Tanimura, H. Hagita, Y. Miyatake, Hiroshi Sakaue and Takafumi Noma : Gene expression analysis of hyperactive mutant SPORTS rat, Cell Symposia:Exercise and Metabolism which takes place at NH Grand Krasnapolsky Hotel Amsterdam from 12-14 July 2015, Amsterdam, Jul. 2015.
9.
Hiroko Hagita, Keiko Miyoshi, Taigo Horiguchi, Ayako Tanimura, Arya Adiningrat, Dian Yosi Arinawati and Takafumi Noma : Analysis of GBA1 gene structure and expression, The 11th International workshop on Advanced Genomics, Tokyo, May 2015.
10.
Keiko Miyoshi, Taigo Horiguchi, Ayako Tanimura, Hiroko Hagita, Yoshihiro Touda, Shoji Kagami, Kenji Mori, Daisuke Tsuji, Kouji Itou and Takafumi Noma : Gaucher disease caused by possible atypical mechanism, Gordon Research Conference, USA,Texas,Galveston(Hotel Galvez), Mar. 2015.
11.
Ayako Tanimura, Taigo Horiguchi, Keiko Miyoshi, Hiroko Hagita and Takafumi Noma : Adenylate Kinase 2 Regulates Neutrophil Differentiation Via Mitochondrial, The 3rd ASEAN Plus and Tokushima Joint International Conference, Makassar,Indonesia, Dec. 2014.
12.
Arya Adinigrat, Ayako Tanimura, Keiko Miyoshi, Ryna Dwi Yanuaryska, Hiroko Hagita, Taigo Horiguchi and Takafumi Noma : Ctip2 Regulation Of Tooth Development Via Sp6 Gene Expression, The 3rd ASEAN Plus and Tokushima Joint International Conference, Makassar,Indonesia, Dec. 2014.
13.
Susumu Tadokoro, Reiko Tokuyama, Seiko Tatehara, Shinji Ide, Hirochika Umeki, Tatsuhiro Fukushima, Keiko Miyoshi, Takafumi Noma and Kazuhito Satomura : A WEW INDUCTION METHOD FOR THE CONTROLLED DIFFERENTIATION OF HUMAN IPS CELLS USING FROZEN SECTIONS, INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH, Vancouver, Jun. 2014.
14.
Ayako Tanimura, Taigo Horiguchi, Keiko Miyoshi, Hiroko Hagita and Takafumi Noma : A role of adenine nucleotide converting enzymes in the mitochondrial intermembrane space on the hematopoietic cell differentiation, Keystone meeting Mitochondrial Dynamics and Physiology, SantaFe, New Mexico, USA, Feb. 2014.
15.
Taigo Horiguchi, Miyuki Fuka, Koichi Fujisawa, Ayako Tanimura, Keiko Miyoshi, Ryutaro Murakami and Takafumi Noma : A Role of AK2 during Development of Drosohila melanogaster, The 4th International Symposium on Dynamics of Mitochondria, Oct. 2013.
16.
Arya Adiningrat, Keiko Miyoshi, Hiroko Hagita, Taigo Horiguchi, Ayako Tanimura, Ryna Dwi Yanuaryska and Takafumi Noma : Role of Bcl11b/Ctip2 on Sp6 Gene Expression in Dental Epithelial Cell, ASEAN PLUS and TOKUSHIMA JOINT INTERNATIONAL CONFERENCE, Dec. 2012.
17.
Ryna Dwi Yanuaryska, Keiko Miyoshi, Taigo Horiguchi, Ayako Tanimura, Hiroko Hagita, Arya Adiningrat and Takafumi Noma : SP6 Regulation of Rock1 Expression in Dental Epithelial Cells, ASEAN PLUS and TOKUSHIMA JOINT INTERNATIONAL CONFERENCE, Tokushima, Dec. 2012.
18.
Keiko Miyoshi, Taro Muto, Taigo Horiguchi, Hiroko Hagita and Takafumi Noma : A frameshift mutation in Sp6 linked to Amelogenesis imperfecta, ASEAN PLUS and TOKUSHIMA JOINT INTERNATIONAL CONFERENCE, Tokushima, Dec. 2012.
19.
Trianna W Utami, Keiko Miyoshi, Hiroko Hagita, Ryna D Yanuaryska, Taigo Horiguchi and Takafumi Noma : REGULATION OF SP6 GENE EXPRESSION AND CELL TYPE SPECIFIC FUNCTION OF SP6 IN DENTAL EPITHELIAL CELLS, The 2nd International Joint Sypmosium on Oral and Dental Sciences In Conjuction with Dental Specialists Seminar, Mar. 2012.
20.
Utami Wahyu Trianna, Keiko Miyoshi, Taigo Horiguchi, Taro Muto, Wahyudi Arie Ivan, Hiroko Hagita and Takafumi Noma : Differential regulation of Sp6 silencing in dental epithelial cells, Inter national Joint Symposium on Oral Science, Dec. 2010.
21.
Ivan Arie Wahyudi, Taigo Horiguchi, Keiko Miyoshi, Taro Muto, Trianna Wahyu Utami, Hagita Hiroko and Takafumi Noma : Caracterization of Specificity Protein 6 promoter Activity, International Joint Symposium on Oral Science, Dec. 2010.
22.
Keiko Miyoshi : Generation of human induced pluripotent stem cells from oral mucosa, Gwangju, republic of Korea, Jun. 2010.
23.
Taro Muto, Keiko Miyoshi and Takafumi Noma : Differentiation of the pigmentation ameloblasts into the pigment release stage is disturbed in incisors of Sp6 transgenic rats, Gordon Resarch Conferences, Apr. 2010.
24.
Takafumi Noma, Taro Muto, Keiko Miyoshi, Taigo Horiguchi, Hiroko Hagita, Wahyudi Arie Ivan and Utami Wahyu Trianna : From a study of tooth morphology and development to a perspective for the future regeneration therapy, ガジャマダ大学 創立62年 記念講演会, Feb. 2010.
25.
Ruspita Intan, Keiko Miyoshi, Taro Muto, Kaori Abe, Taigo Horiguchi and Takafumi Noma : Identification of Sp6 target gene in dental epithelial cells, Gordon Research Conferences, Feb. 2008.
26.
Keiko Miyoshi, Taigo Horiguchi, Kazuki Abe, Inoue Hideo and Takafumi Noma : Effects of glycyrrhizin on the gene expression in CC14-induced hepatitis, 8th World Congress on Inflammation, Jun. 2007.
27.
Takafumi Noma, Keiko Miyoshi, Yuki Akazawa and Taigo Horiguchi : Tissue-ditribution and possible functional roles of AK4, Mitchondrial Medicine 2007: Riding the Wave of the Future, Jun. 2007.
28.
Takafumi Noma, Keiko Miyoshi, Yuki Akazawa and Taigo Horiguchi : Tissue-distribution and possible functional roles of AK4, Mitochondrial Medicine Meeting, San Diego, Jun. 2007.
Kaori Abe, Keiko Miyoshi, Taro Muto, Intan Ruspita, Taigo Horiguchi, Toshihiko Nagata and Takafumi Noma : Establishment and charactarization of rat ameloblast-lineage clones, The 19th Annual and International Meeting of the Japanese Association for Animal Cell Technology, Kyoto, Sep. 2006.
30.
Taro Muto, Keiko Miyoshi, Hiroshi Nakata, Seiichi Munesue, Minoru Okayama, Takashi Matsuo and Takafumi Noma : Comparative analysis of syndecan expression during mouse incisor development, Extracellular Glycomatrix in health and Disease symposium, Awaji, Jun. 2006.
31.
Intan Ruspita, Taigo Horiguchi, Keiko Miyoshi, Akemichi Ueno, Hidemitsu Harada and Takafumi Noma : Regulation of Gene Expression in Dental Epithelial Cells, Eighth International Conference on Tooth Morphogenesis and Differentiation, York, UK, Jul. 2004.
32.
Keiko Miyoshi, Taigo Horiguchi, Kaori Abe, Akemichi Ueno, Hideya Nagata, Yoshinobu Baba, Hidemitsu Harada and Takafumi Noma : Effects of BMP2 on Gene Expression in Dental Epithelial Cell Line, Eight International Conference on Tooth Morphogenesis and Differentiation, York, UK, Jul. 2004.
Proceeding of Domestic Conference:
1.
(名) Lutfi, Raman Swarna, (名) Jaime, (名) Dara, Masamitsu Ohshima, Daisuke Ikutame, Keiko Miyoshi and Yoshizo Matsuka : β-endorphin induced by rIL-10 serves as a potential target for alleviating trigeminal neuropathic pain, The 49th Okayama Brain Research Seminar, Sep. 2024.
2.
Putra Lutfi Perdana, Swarna Lakshmi Raman, Fabillar Jr. Jaime Moreno, Arini Sari Dara, Masamitsu Ohshima, Daisuke Ikutame, Keiko Miyoshi and Yoshizo Matsuka : Pain-relief mechanism of IL-10 in the trigeminal ganglia: insights into trigeminal neuropathic pain management, Brain Science cluster minirtreat, Feb. 2024.
3.
Jin Shengjian, Takaaki Tsunematsu, Taigo Horiguchi, Yasuhiro Mouri, Wenhua Shao, Keiko Miyoshi, Noriko Mizusawa, Hagita Hiroko, Sarubo Motoharu, Yoshida Kayo, Kaya Yoshida, Natsumi Fujiwara, Kazumi Ozaki, Naozumi Ishimaru and Yasusei Kudo : The role of deubiquitinating enzyme, OTUB1 in head and neck squamous cell carcinoma (HNSCC) progression, 第82回日本癌学会学術集会, Sep. 2023.
4.
Jin Shengjian, Takaaki Tsunematsu, Taigo Horiguchi, Yasuhiro Mouri, Wenhua Shao, Keiko Miyoshi, Noriko Mizusawa, Hiroko Hagita, YOSHIDA Kayo, Kaya Yoshida, Natsumi Fujiwara, Kazumi Ozaki, Naozumi Ishimaru and Yasusei Kudo : The role of Deubiquitinating enzyme, OTUB1 in head and neck squamous cell carcinoma (HNSCC) progression, 第61回四国歯学会, Mar. 2023.
Arinawati Yosi Dian, Keiko Miyoshi, Hagita Hiroko, Taigo Horiguchi and Takafumi Noma : Perturbation of gene regulateion in an in vitro amelogenesis imperfecta model, The 91st Annual Meeting of the Japanese Biochemical Society, Sep. 2018.
Arinawati Yosi Dian, Keiko Miyoshi, Hagita Hiroko, Taigo Horiguchi and Takafumi Noma : Demonstration of defective amelogenesis using an in vitro amelogenesis imperfecta model, 第257回徳島医学会学術集会, Aug. 2018.
13.
Keiko Miyoshi, hagita hiroko, Ayako Tanimura, Taigo Horiguchi and Takafumi Noma : 5´end structure of GBA and expression profile of its variants, 2017年度生命科学系学会合同年次大会 ConBio 2017, Dec. 2017.
Ayako Tanimura, Keiko Miyoshi, Taigo Horiguchi, Koichi Fujisawa and Takafumi Noma : CRISPR/Cas9を用いたAK2の段階的欠損による細胞代謝への影響, The 2nd ANNUAL MEETING OF THE JAPANESE SOCIETY FOR GENOME EDITING, Jun. 2017.
17.
Keiko Miyoshi : 口腔粘膜線維芽細胞の代謝と細胞の特性∼トランスクリプトーム解析からのアプローチ∼, 第122回日本解剖学会 総会・全国学術集会, Mar. 2017.
18.
Ayako Tanimura, Taigo Horiguchi, Keiko Miyoshi, Arinawati Yosi Dian and Takafumi Noma : HL-60細胞を用いた血球分化時におけるUnfolded protein responseの解析, 第57回 日本生化学会 中国・四国支部例会, May 2016.
Keiko Miyoshi, Taigo Horiguchi, Ayako Tanimura, Hiroko Hagita and Takafumi Noma : ヒト口腔粘膜線維芽細胞の特性:皮膚線維芽細胞，iPS細胞との網羅的遺伝子発現の比較解析, The 14th Congress of the Japanese Society for Regenerative Medicine, Mar. 2015.
21.
Arya Adiningrat, Keiko Miyoshi, Ryna Dwi Yanuaryska, Hiroko Hagita, Taigo Horiguchi, Ayako Tanimura and Takafumi Noma : Establishment and Characterization of Dental Epithelial Cells Derived from Amelogenesis Imperfecta Rat, 第87回日本生化学会大会, Oct. 2014.
22.
Arya Adiningrat, Ayako Tanimura, Keiko Miyoshi, Ryna Dwi Yanuaryska, Hiroko Hagita, Taigo Horiguchi and Takafumi Noma : Ctip2 role in Sp6 transcriptional regulation in dental epithelial-derived cells, 2014 Tokushima Bioscience Retreat, Sep. 2014.
23.
Keiko Miyoshi : 口腔粘膜線維芽細胞の有用性とiPS細胞を用いた再生歯科学へのアプローチ, 第12回日本再生歯科医学会学術大会・総会, Aug. 2014.
24.
Adiningrat Arya, Ayako Tanimura, Keiko Miyoshi, Yanuaryska Dwi Ryna, Taigo Horiguchi, 萩田 浩子 and Takafumi Noma : Role of Ctip2 in Sp6 gene regulation, 第36回日本分子生物学会年会, Dec. 2013.
Utami Wahyu Trianna, Keiko Miyoshi, Hiroko Hagita, Yanuaryska D Ryna, Ayako Tanimura and Takafumi Noma : Regulation of Sp6 expression and function in dental epithelial cells, 第5回 日本エピジェネティクス研究会, May 2011.
39.
Utami Wahyu Triannna, Keiko Miyoshi, Taigo Horiguchi, Wahyudi A Ivan, Hiroko Hagita, Yanuaryska D Ryna and Takafumi Noma : Regulation of Sp6 expression and function in C9 cells, 第52回 日本生化学会中国 四国支部例会, May 2011.
40.
Utami Wahyu Trianna, Keiko Miyoshi, Taigo Horiguchi, Taro Muto, Wahyudi Arie Ivan, Hiroko Hagita and Takafumi Noma : Regulation of Sp6 expression in CHA9 cells, 第33回 日本分子生物学会 第83回日本生化学会, Dec. 2010.
41.
Wahyudi Arie Ivan, Taigo Horiguchi, Keiko Miyoshi, Taro Muto, Utami Wahyu Trianna, Hiroko Hagita and Takafumi Noma : Isolation and Characterization of Mouse Specificity Protein 6 Promoter, 第33回 日本分子生物学会 第83回 日本生化学会, Dec. 2010.
Wahyudi Arie Ivan, Taigo Horiguchi, Keiko Miyoshi, Taro Muto and Takafumi Noma : Regulation of Sp6 expression in dental epithelial cells, 第51回 歯科基礎医学会, Sep. 2009.
48.
Ruspita Ita, Keiko Miyoshi, Taro Muto, Taigo Horiguchi, Kaori Abe, Takafumi Noma and Toshihiko Nagata : A possible role of Sp6 in Amelogenesis, 「魅力ある大学院教育」イニシアティブ 「21世紀の口腔科学が目指すべき方向性」, Dec. 2007.
49.
Ruspita Intan, Keiko Miyoshi, Taro Muto, Taigo Horiguchi, Kaori Abe and Takafumi Noma : Sp6 induced down-regulation of follistatin gene in rat dental epithelial cells, 第49回歯科基礎医学学術大会, Aug. 2007.
50.
Kaori Abe, Keiko Miyoshi, Taro Muto, Taigo Horiguchi, Ruspita Intan, Toshihiko Nagata and Takafumi Noma : Redox regulation of amelogenin gene expression, 第49回歯科基礎医学学術大会, Aug. 2007.
51.
Kaori Abe, Keiko Miyoshi, Taro Muto, Taigo Horiguchi, Ruspita Ita, Takafumi Noma and Toshihiko Nagata : MAPK activation via ROS induces amelognin expression in the ameloblast-lineage cells, 「魅力ある大学院教育」イニシアティブ 「21世紀の口腔科学が目指すべき方向性」, 2007.
52.
Akemichi Ueno, Kikuji Yamashita, Keiko Miyoshi, Taigo Horiguchi, Ruspita Intan, Kaori Abe and Takafumi Noma : Overexpression of thrombospondin1(TSP1) inhibits mineralization by MC3T3 cells in vivo, 77th mass Meeting of the Japanese Biochemical Society, Oct. 2004.
53.
Keiko Miyoshi, 堀口 大吾, Akemichi Ueno, 長田 英也, 馬場 嘉信 and Takafumi Noma : 歯原性上皮細胞株でのBM2シグナルによる遺伝子発現の変化, 第45回日本生化学会・四国支部例会, May 2004.
54.
Keiko Miyoshi, 堀口 大吾, Akemichi Ueno and Takafumi Noma : 組織および細胞株におけるpitx2アイソフォーム遺伝子の発現パターン解析, 45th Annual Meeting of Japanese Association for Oral Biology, Sep. 2003.
Et cetera, Workshop:
1.
Lutfi P. Perdana, Swarnalakshmi Raman, Jaime Jr. Fabillar, Dara S. Arini, Masamitsu Ohshima, Daisuke Ikutame, Keiko Miyoshi and Yoshizo Matsuka : Antinociceptive mechanism of IL-10 in trigeminal ganglia of trigeminal neuropathic pain model, Feb. 2024.
The identification of genes involved in the maintenance and regeneration of salivary gland stem / progenitor cells and application to new xerostomia treatment (Project/Area Number: 22K10121 )
Establishment of the new diagnosis biomarkers for metal allergy by analyzing peripheral blood miRNA expression (Project/Area Number: 20K10038 )
Explore of the GBA translation regulatory mechanism by RNA epigenetics: To find the therapeutic targets for Gaucher disease (Project/Area Number: 19K10043 )
Metal allergy; What is the difference between sensitization and onset? -Identification of specific genes- (Project/Area Number: 16K11599 )
Characterization of Gaucher disease by new gene mutation using patient-derived oral mucosa fibroblasts (Project/Area Number: 15K11041 )
Establishment of disease model system using patient-derived oral mucosa fibroblast-iPSCs and development of new therapy (Project/Area Number: 24592801 )
Relationship between transcriptional activity and structure of tooth specific transcription factor Sp6 and identification of its interaction molecules (Project/Area Number: 21791805 )